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The mechanisms of apoptosis in pancreatic acinar cells and the mechanisms by which 
induction of acinar cell apoptosis protects against acute pancreatitis were investigated. 
The results summarized below are the major findings of the present work. 
 
1. The effect of crambene (1-cyano-2-hydroxy-3-butene-CHB), a plant nitrile, on 
cell death of isolated pancreatic acinar cells was examined. We have shown that 
crambene stimulates apoptosis but not necrosis of pancreatic acinar cells as evidenced 
by annexin V-FITC staining. Caspase 3, 8 and 9 activation in treated acini were 
significantly increased compared to untreated acini. However, the kinetics of caspase 
8 and 9 always preceded caspase 3 activation. In addition, treatment with caspase 3, 8, 
and 9 inhibitors significantly attenuated both annexin V staining and caspase 3 
activation. These results indicate an important role of caspase 3, 8 and 9 activation in 
the crambene-induced apoptosis in pancreatic acinar cells. Moreover, the 
mitochondrial membrane potential was collapsed and cytochrome c was released 
from the mitochondria in crambene-treated acini. These results provide evidence for 
the induction of apoptosis by crambene in isolated pancreatic acinar cells in vitro, and 
suggest that crambene induces caspases activation and mitochondrial dysfunction in 
pancreatic acinar cells.  
 
2. The mechanisms by which induction of pancreatic acinar cell apoptosis 
protects against acute pancreatitis were investigated.  The phagocytic clearance of 
 2
apoptotic acinar cells and the regulation of inflammatory mediators were investigated 
as possible mechanisms of crambene-mediated protection against acute pancreatitis. 
Using caerulein-induced experimental acute pancreatitis in vivo and co-cultures of 
peritoneal resident macrophages with isolated pancreatic acinar cells in vitro as the 
experimental systems, expression of phagocytic receptors was evaluated via RT-PCR, 
western blotting and immunostaining; levels of inflammatory mediators were 
investigated via ELISA. Apoptosis in pancreatic sections was visualized by terminal 
deoxynucleotidyltransferase-mediated dUTP-biotin nick-end labeling (TUNEL). 
Severity of acute pancreatitis was evaluated by estimation of serum amylase, 
pancreatic myeloperoxidase (MPO), water content, and morphological examination. 
Moreover, a role of anti-inflammatory pathways as the mechanism of apoptosis-
mediated protection against acute pancreatitis was established by using the 
neutralizing monoclonal anti-IL-10 antibody (2.5 mg/kg) before the induction of 
apoptosis in acute pancreatitis, to test if the protection from apoptosis would be 
removed. Our study demonstrated that phagocytosis of apoptotic acinar cells in acute 
pancreatitis may be essentially through CD36 positive macrophages. Moreover, 
phagocytosis of apoptotic acinar cells stimulates the release of anti-inflammatory 
mediators such as IL-10; and IL-10 plays an important role in crambene-induced 
protection against acute pancreatitis. Besides up-regulation of IL-10 by phagocytosis, 
the protective effect of crambene is also mediated by down-regulation of pro-
inflammatory cytokines such as MCP-1, TNF-α and IL-1β. Therefore, we concluded 
that induction of apoptosis in pancreatic acinar cells by crambene protects mice 
against acute pancreatitis via induction of anti-inflammatory pathways. 
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CHAPTER 1: GENERAL INTRODUCTION 
 
1.1 General overview 
Acute pancreatitis is a common disorder with potentially devastating consequences. 
The incidence of the disease differs geographically; however, the death rate of it has 
remained high at 8-13% over the past 20 years (Bhatia, Brady et al. 2000a; Bhatia, 
Neoptolemos et al. 2001; Bhatia 2002; Bhatia, Brady et al. 2002; Bhatia and 
Moochhala 2004). The severity of acute pancreatitis varies from a mild, self-limited 
course to a severe life-threatening illness, which is often associated with 
multisystemic organ failure. The exact mechanisms by which diverse etiological 
factors induce the attack are still unclear; several recent studies, however, have shown 
that the severity of acute pancreatitis was inversely related to the extent of pancreatic 
acinar apoptosis (Kaiser, Saluja et al. 1995; Gukovskaya, Perkins et al. 1996; Bhatia 
2004). Moreover, it has also been demonstrated that induction of apoptosis reduces 
the severity of experimental pancreatitis, while inhibition of it worsens the disease 
(Bhatia, Wallig et al. 1998; Frossard, Rubbia-Brandt et al. 2003). These studies 
suggested that apoptosis is a teleologically beneficial form of cell death in acute 
pancreatitis. 
 
However, little is known about the molecular mechanisms of pancreatic acinar cell 
death and how the induction of apoptosis in pancreatic acinar cells protects against 
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acute pancreatitis (Wallig, Gould et al. 1988; Wallig, Kore et al. 1992; Bhatia, Wallig 
et al. 1998; Gerasimenko, Gerasimenko et al. 2002; Gukovskaya, Gukovsky et al. 
2002).  
 
The present chapter first reviews the pathophysiology of both clinical and 
experimental acute pancreatitis. Subsequently, it reviews literature regarding the 
mechanisms of apoptosis. Afterwards, the mechanisms of apoptosis in acute 
pancreatitis and several compounds that could induce apoptosis of pancreatic acinar 
cells are generally discussed. Lastly, the research questions and aims of the study are 
proposed. 
 
1.2 Pathophysiology of clinical acute pancreatitis 
Acute pancreatitis is an acute inflammatory process of the pancreas, which is 
associated with pancreatic edema, autodigestion, necrosis and possible hemorrhage. 
The most common etiological factors of this disease include biliary disease and 
excess alcohol consumption (Fred S. Gorelick 1993). 
 
The severity of acute pancreatitis varies from a mild, self-limited course to a severe 
life-threatening illness, which is often associated with multisystemic organ failure. 
Noticeably, up to 25% of patients suffer a severe attack and between 30% to 50% of 
them will die (Bhatia, Brady et al. 2000a; Bhatia, Neoptolemos et al. 2001; Bhatia, 
Brady et al. 2002; Uhl, Warshaw et al. 2002; McKay and Buter 2003; Bhatia and 
Moochhala 2004). There are two situations among mortal cases in acute pancreatitis 
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(Bhatia, Brady et al. 2000; Bhatia, Neoptolemos et al. 2001; Bhatia, Brady et al. 2002; 
Bhatia and Moochhala 2004). In the first situation, patients die from acute pancreatitis 
within the first week. These patients usually suffer a severe initial attack and develop 
exaggerated systemic inflammatory response syndromes (SIRS) with the 
development of multi-organ dysfunction syndrome (MODS). In the second situation, 
patients with a severe attack survive the initial overactive SIRS insult, but they often 
die later following a relatively minor second event that would not normally be life-
threatening, such as a minor injury. However, in this situation, recovery is possible if 
no further insult occurs (Bhatia, Brady et al. 2000; Bhatia, Neoptolemos et al. 2001; 
Bhatia, Brady et al. 2002; Bhatia and Moochhala 2004). In both situations described 
here, the initial overactive SIRS somehow prime the inflammatory response and 
become a critical determinant of acute pancreatitis.   
 
The progression of acute pancreatitis can be viewed as a three-phase continuum: local 
inflammation of the pancreas, a systemic inflammatory response and the final stage of 
multi-organ dysfunction (Bhatia, Brady et al. 2000a; Bhatia, Neoptolemos et al. 2001; 
Bhatia, Brady et al. 2002; Bhatia and Moochhala 2004). During the whole 
progression, inflammatory mediators (such as cytokines, chemokines etc) appear to 
play a critical role in the pathogenesis of pancreatitis and more so in the subsequent 
inflammatory response (Bhatia, Brady et al. 2000a; Bhatia, Neoptolemos et al. 2001; 
Bhatia, Brady et al. 2002; Bhatia and Moochhala 2004). As early as in 1988, it was 
first hypothesized that cytokines might play an important role in acute pancreatitis 
and the inappropriate activation of the immune system might increase the severity of 
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both local disease and systemic complications (Rinderknecht 1988). At present, 
mediators believed to participate in the progression of acute pancreatitis include: 
Tumor necrosis factor-α (TNF-α) (Hughes CB, Grewal HP et al.1996; Mayer J, Rau 
B et al. 2000), Interleukin-1β (IL-1β) (Mayer J, Rau B et al. 2000), interleukin10 (IL-
10) (Rongione AJ, Kusske AM et al.1997; Dembinski A, Warzecha Z et al. 2001), 
monocyte chemoattractant protein-1 (MCP-1) (Bhatia, Brady et al. 2000a), substance 
P (Bhatia M, Saluja AK et al. 1997; Maa J, Grady EF et al. 2000; Bhatia M, Slavin J 
et al. 2003), H2S (Bhatia M, Wong FL Z et al. 2005), etc. The expression of several 
mediators are regulated by transcription factors such as NF-κB (Mercurio and 
Manning 1999; Algul, Tando et al. 2002). 
 
Besides systemic inflammatory responses, recent studies suggest that the pancreatic 
acinar cell injury and the subsequent pancreatic acinar cell death responses to that 
injury may themselves be important determinants of the severity of acute pancreatitis. 
It is now widely accepted that the injury of pancreatic acinar cells is a critical 
initiating event that leads to inflammation of pancreas (Bhatia, Brady et al. 2000a; 
Bhatia, Neoptolemos et al. 2001; Bhatia, Brady et al. 2002; Bhatia and Moochhala 
2004). Injury or disruption of the pancreatic acini permits leakage of pancreatic 
enzymes (such as trypsin, chymotrypsin and elatase) into pancreatic tissue. The 
leaked enzymes become activated in the tissue and break down cell membranes as 
well as tissue, causing pancreatic edema, vascular damage, hemorrhage and necrosis. 
Thus, inflammation and acute pancreatitis are initiated (Figarella C, Miszczuk-
Jamska B. et al. 1988; Saluja AK, Bhagat L. et al. 1999). In addition to leading 
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inflammation of pancreas, the injury of pancreatic acinar cell may also cause two 
kinds of observable cell death in acute pancreatitis: pancreatic acinar cell necrosis and 
apoptosis (Gukovskaya AS, Perkins P et al. 1996; Bhatia M. 2004). Interestingly, 
severe acute pancreatitis is shown to be primarily associated with necrosis but 
minimal apoptosis, whereas mild acute pancreatitis is associated primarily with 
apoptosis but minimal necrosis (Kaiser, Saluja et al. 1995; Gukovskaya, Perkins et al. 
1996; Bhatia 2004). Detailed information will be reviewed in section 1.4.3. 
 
1.3 Pathophysiology of experimental acute pancreatitis 
Although the formal characterization of acute pancreatitis was decided more than one 
hundred years ago, there has been little progress in the pathogenesis and therapy of 
this disease (Bilchik, Leach et al. 1990). In order to develop rationale concepts 
concerning pathogenesis and therapy, investigators have developed a variety of 
experimental animal models of pancreatitis, which are helpful tools to study acute 
pancreatitis. Generally, the experimental models of acute pancreatitis can be grouped 
into invasive and non-invasive ones according to methods, or divided into acute 
edematous pancreatitis and acute severe pancreatitis as determined by morphology 
(Lampel and Kern 1977). In this section, caerulein induced severe acute pancreatitis 






1.3.1 Induction of acute pancreatitis in mice by caerulein injections 
Compared to invasive models of acute pancreatitis (such as closed duodenal loop 
technique, duct ligation models, duct perfusion/injection models, etc) which are 
characterized by extensive and uncontrolled pancreatic destruction, caerulein model is 
relatively noninvasive, nonlethal, easy to use, inexpensive, and highly reproducible 
(Lampel and Kern 1977). This widely used model of acute pancreatitis provides an 
experimental system for accurately examining the onset and development of 
experimental acute severe pancreatitis. 
 
The most often used approach to build up this model is to give mice hourly 
intraperitoneal injections of saline containing a supramaximally stimulating 
concentration of caerulein (50 µg/ kg) for 10 hours (Bhatia, Brady et al. 2000b), 
which has been found to induce severe acute pancreatitis in mice (Niederau, Ferrell et 
al. 1985). The maximal pancreatic injury in mouse occurs within 10 hours.  
 
1.3.2 Principle of caerulein-induced experimental acute pancreatitis in mice 
Caerulein is an amphibian peptide that has the same biologic activity as 
cholecystokinin (CCK). CCK is a peptide hormone of the gastrointestinal system 
responsible for stimulating the digestion of fat and protein. Released from the 
duodenum, CCK acts on the pancreas to stimulate the secretion of a juice rich in 
digestive enzymes, such as trypsinogen, chymotrypsinogen, amylase, lipase, and 
maltase (Korc M, Bailey AC et al. 1981; Korc M, 1982). Besides stimulating 
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digestive enzymes, CCK also acts as a neuropeptide, mediating satiety by acting on 
the CCK receptors that are distributed widely throughout the central nervous system 
(Shillabeer G and Davison JS, 1987; Greenough A, Cole G et al. 1998; Fink H, Rex 
A et al. 1998). 
 
CCK stimulates protein secretion in a dose dependent manner (Saluja A. K., Saluja M. 
et al. 1989; Bragado MJ, Tashiro M. et al. 2000) However, doses of CCK that 
provide maximal stimulation of protein secretion are associated with increased rates 
of protein synthesis (Bragado MJ, Tashiro M. et al. 2000). In that case, if the maximal 
stimulation persists for a period of time, the increase of protein synthesis will be 
outpaced by the rate of protein secretion. This results in reduction of enzyme stores of 
the exocrine pancreas (Scheele and Palade 1975). However, if the doses of CCK 
increase over the doses that provide the maximal stimulation, the supramaximal 
stimulation happens. The supramaximal stimulation generates paradoxical pancreatic 
responses, such as diminished secretion, accumulation of secretory proteins within the 
pancreas, and pancreatic injury (Lampel and Kern 1977). In caerulein-induced 
experimental acute pancreatitis, the doses of caerulein provide a supramaximal 
stimulation. This is the principle of caerulein-induced experimental acute pancreatitis 






1.3.3 Characteristics of caerulein-induced pancreatitis 
The caerulein-induced pancreatic damage is characterized by increased serum levels 
of pancreatic enzymes, edema, inflammation and pancreatic acinar cell injury 
(Niederau, Ferrell et al. 1985).  
 
1.3.3.1 Increase in levels of pancreatic enzymes in the serum 
One of the hallmarks in human pancreatitis is an increase in the level of pancreatic 
enzymes within the serum (Clavien PA, Burgan S. et al. 1989; Yadav D, Agarwal N. 
et al. 2000). In mouse models of caerulein-induced pancreatitis, serum levels of 
amylase increase rapidly with increasing time and dose of caerulein injection 
(Luthenre, Niederau C. et al. 1995; Kusama K, Nozu F. et al. 2003). The exact 
mechanisms responsible for the increase of pancreatic enzymes in the serum are till 
unknown (Yadav D, Agarwal N. et al. 2002). However, studies suggest that 
pancreatic enzymes may gain entry into the interstitial and intravascular space 
following pathological exocytotic release at the basolateral membrane of the acinar 
cell (Leach SD, Modlin IM. et al. 1991; Marshall JB, 1993). Alternatively, changes in 
junctional permeability may allow the enzymes to pass from the pancreatic duct into 
interstitium (Fred S. Gorelick 1993). 
 
1.3.3.2 Pancreatic edema 
Pancreatic edema is an obvious character during caerulein hyperstimulation. 
According to previous studies, the following factors may contribute to the cause of 
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pancreatic edema formation: 1) increased vascular permeability, 2) increased 
hydrostatic pressure from small vessel constriction or obstruction, and 3) increased 
tissue oncotic pressure from the interstitial release of pancreatic enzymes and 
hydrolysis products (Fred S. Gorelick 1993). 
 
1.3.3.3 Neutrophil infiltration 
In caerulein-induced pancreatitis, neutrophils appear within 1 hour and peak numbers 
of neutrophils are reached within 6 to 10 hour (Folch E, Closa D. et al. 1998; 
Frossard JL and Pastor CM, 2002). The infiltration of neutrophils has been shown to 
be involved in the development of pancreatic and pulmonary injury in acute 
pancreatitis (Guice KS, Oldham KT. et al. 1989). The mechanisms initiating 
neutrophils infiltration are poorly understood. However, it is generally believed that 
acinar cell injury and the released pancreatic proteases induce the recruitment of 
circulating neutrophils (Hofbauer B, Saluja A. et al. 1998; Norman J, 1999; Saluja 
AK, Bhagat L et al. 1999; Formelalj, Gallowasy SW et al. 1995; Bhatia M, Brady M 
et al. 2000b; Halangk W, Lerch M, et al. 2000; Frossard JL and Pastor CM 2002). 
According to these studies, acinar cell injury and the released pancreatic proteases 
trigger the up regulation of series of factors, which contribute to neutrophils 
infiltration. These factors include adhesion molecules such as ICAM-1 and P-selectin 
(Hartwig, Werner et al. 2004; Genovese, Mazzon et al. 2006), cytokines such as 
TGF-β1 (Schafer, Tietz et al. 2005), chemokines such as MCP-1/JE (Brady, Bhatia et 
al. 2002) and neuropeptide such as substance P (Noble, Romac et al. 2006). The 
activated neutrophils, moreover, lead to further acinar cell injury and are responsible 
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for the systemic inflammatory response which is typically observed in severe acute 
pancreatitis (Raraty, Murphy et al. 2005). 
 
1.3.3.4 Pancreatic acinar cells injury 
Pancreatic acinar cell injury is a well-known initiating event of acute pancreatitis. The 
injury of pancreatic acinar cell is highly reproducible and in direct relationship to 
both time and dose of caerulein injection.  
 
Morphologically, pancreatic acinar cell injury includes acinar cell vacuolization and 
necrosis. Examined by light microscopy, the cell injury exhibits (i) the presence of 
acinar-cell ghosts; (ii) vacuolization and swelling of acinar cells or (iii) the 
destruction of the histoarchitecture of the whole or parts of the acini (Bhatia, Saluja et 
al. 1998; Bhatia, Brady et al. 2000b; Bhatia, Slavin et al. 2003; Bhatia, Wong et al. 
2005). The electron microscopic changes of pancreatic acinar cell injury include (i) 
dilatation of the endoplasmic reticulum, (ii) condensation of nuclear chromatin, (iii) 
loss in the definition of the plasmalemmal membrane, (iv) formation of large 
cytoplasmic vacuoles near the Golgi complex, and v) disruption of apical domain of 
the cell which may be shed into the acinar lumen (Fred S. Gorelick 1993). All these 
cellular changes are associated with an inflammatory reaction during acute 
pancreatitis.  
 
Biochemically, the pathologic processes of cellular changes in caerulein-induced 
pancreatitis comprise: (a) inhibition of the normal transport of exocrine proteins, (b) 
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changes in the cellular compartmentation of exocrine proteins, and (c) activation of 
exocrine digestive enzymes within pancreatic tissue (Fred S. Gorelick 1993). These 
pathologic processes are interrelated and together contribute to the damage of 
pancreas. For example, studies have shown that the occupancy of low-affinity 
receptor by supramaximal doses of caerulein and redistribution of subapical F-actin 
may lead to (a); (a) has been shown to mediate colocalization of digestive enzyme, 
which causes (b); (b) is believed to cause (c) via the phospholipase C/inositol 
trisphosphate/Ca2+/PKC signal transduction pathway. Furthermore, intracellular 
activation of digestive enzyme zymogens is believed to cause both acinar cell injury 
and pancreatitis (Saluja, Saluja et al. 1989; Hofbauer, Saluja et al. 1998; Frossard, 
Bhagat et al. 2002; Perides, Sharma et al. 2005).  
 
Abnormal patterns in the intracellular calcium signaling also play an important role to 
acinar cell injury (Criddle DN, McLaughlin E. et al. 2007). Pancreatitis induced by 
caerulean hyperstimulation and by pancreatic duct obstruction has been shown to 
cause a rise in intracellular Ca2+ and a disruption of acinar cell Ca2+ signaling (Bhatia 
M, Brady M et al. 2000; Raraty M, Ward J et al. 2000; Mooren FCh, Hlouschek V et 
al. 2003). This is associated with acinar cell vacuolization and the intracellular 
trypsinogen activation events that occur in early acute pancreatitis (Bhatia M, Brady 
M et al. 2000; Raraty M, Ward J et al. 2000; Mooren FCh, Hlouschek V et al. 2003). 
Although these evidences suggest that intracellular Ca2+ plays a central role in 
intracellular trypsinogen activation, it is unclear if disruption in Ca2+ signaling alone 
is sufficient for this effect. Incubation of pancreatic acini with Ca2+-ATPase inhibitor 
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thapsigargin caused trypsinogen activation in one study (Raraty M, Ward J et al. 2000) 
but not in another study (Saluja AK, Bhagat L et al. 1999), which was published 
around the same time. Therefore, more research is needed to clearly define the role of 
Ca2+ in trypsinogen activation.  
 
Besides the Ca2+ signaling, trypsinogen autoactivation requires an acidic pH 
(Sherwood MW, Prior IA, et al. 2007, Figarella C, Miszczuk-Jamska B et al. 1988). 
The affinity of pancreatic trypsin inhibitor is greatest at a neutral pH and is reduced at 
an acidic pH (Sherwood MW, Prior IA, et al. 2007, Figarella C, Miszczuk-Jamska B 
et al. 1988). Therefore, the generation of low-pH compartments within the acinar cell 
during experimental pancreatitis may be important to trypsinogen activation. 
 
Besides the above pathologic processes, some studies suggest that supramaximal 
doses of caerulein themselves may lead to the membrane damage in acinar cells. 
Since the membrane damage allows large molecules to enter the cytosol, this also 
contributes to cellular changes such as vacuoles and membrane fusion in acute 
pancreatitis (M.W. Müller, D.E. Bockman et al 2003; Bockman DE, Guo J et al 
2004). 
 
The ultimate cellular response to acinar cell injury is acinar cell death. The acinar cell 
death in acute pancreatitis, which is the focus of the current study, will be discussed 
in the following sections. 
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1.4 Acinar cell death in acute pancreatitis 
Progressive pancreatic acinar cell death is a hallmark in clinical as well as in 
experimental acute pancreatitis, and the mechanisms of which remain poorly 
understood (Bhatia 2004). Necrosis has been considered as the major form of cell 
death in acute pancreatitis, and the extent of pancreatic necrosis is strongly associated 
with the prognosis of this disease (Nevalainen and Aho 1992; Kloppel and Maillet 
1993). On the other hand, apoptosis has long been suggested to mediate the 
destruction of acinar cells and induce atrophy of the organ (Walker 1987; Walker, 
Winterford et al. 1992; Jimi, Kojiro et al. 1997).  
 
However, careful biochemical and morphological examination of experimental 
models of acute pancreatitis has shown that severe acute pancreatitis (e.g. that 
induced by pancreatic duct ligation in the opossum, by choline-deficient and 
ethionine supplemented diet in the mouse, and by caerulein-hyperstimulation in the 
mouse) is primarily associated with necrosis but minimal apoptosis, whereas mild 
acute pancreatitis (e.g. that induced by pancreatic duct ligation and by caerulein-
hyperstimulation in the rat) is primarily associated with apoptotic cell death and 
minimal necrosis (Kaiser, Saluja et al. 1995; Gukovskaya, Perkins et al. 1996). In 
other words, the severity of acute pancreatitis is inversely related to the extent of 
acinar cell apoptosis. Moreover, induction of apoptosis reduces the severity of 
experimental pancreatitis, while inhibition of it worsens the disease (Bhatia, Wallig et 
al. 1998; Hahm, Kim et al. 1998; Frossard, Rubbia-Brandt et al. 2003; Lupia, Goffi et 
al. 2004; Chao, Chao et al. 2006). These studies suggested that apoptosis is a 
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teleologically beneficial form of cell death in acute pancreatitis. Hence, elucidating 
the molecular mechanisms of pancreatic cell apoptosis and how it benefits against 
acute pancreatitis would provide valuable insights into clinical pancreatic disorders 
and offer potential pharmacological interventions.  
 
In the current section, literature regarding the cell death and the mechanisms of 
apoptosis is reviewed at first. Then, the mechanism of apoptosis in acute pancreatitis 
and several compounds that can or could induce apoptosis of pancreatic acinar cell 
are generally discussed. 
 
1.4.1 Two alternative forms of cell death 
There are two alternative forms of cell death, apoptosis and necrosis.  The term 
“apoptosis” was first coined by Currie and his colleagues in 1972, to describe a form 
of cell death that distincts from necrosis (Kerr, Wyllie et al. 1972; Hengartner 2000). 
Initially, apoptosis was recognized as “programmed cell death,” a type of cell death 
that serves to eliminate excessive or unwanted cells in the course of organ 
development. Nowadays, “apoptosis” is one of the most frequently used words in 
biology and medicine and is known to play a key role in a variety of biological events, 
including cell differentiation, organogenesis and various disease conditions (Steller 
1995; Thompson 1995). Many cellular changes that take place in apoptotic cells have 
an important role in the induction of phagocytosis by their neighboring cells or by 
phagocytes (Devitt, Moffatt et al. 1998; Fadok, Bratton et al. 2000). The 
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distinguishable characters of apoptosis compared to necrosis, is that apoptosis does 
not involve a pro-inflammatory response.  
 
Necrosis, on the other hand, has been considered as a “passive” degenerative 
phenomenon induced by direct toxic or physical injuries, which often occurs 
accidentally. During the process of necrosis, adenosine triphosphate (ATP)-dependent 
ion channels become ineffective, leading to ion dyshomeostasis, disruption of the 
actin cytoskeleton, cell swelling, and eventual collapse of the cell (Carini, Autelli et 
al. 1995; Maeno, Ishizaki et al. 2000; Okada, Maeno et al. 2001). Meanwhile, nuclear 
DNA is randomly cleaved as a consequence of cellular degeneration. Unlike 
apoptosis, necrosis causes significant pro-inflammatory responses, such as cellular 
inflammatory responses and general inflammatory reactions. These inflammatory 
responses induced by necrosis may be due to the disruption of plasma membrane and 
leakage of intracellular components (Hawkins, Ericsson et al. 1972; Alison and Sarraf 
1994). The distinction of morphological and biochemical features between apoptosis 












Membrane blebbing, but no loss of 
integrity Loss of membrane integrity 
Cells shrink, ultimately forming 
apoptotic bodies Cells swell and lyse 
No inflammatory response Significant inflammatory response 
Compaction of chromatin into 
uniformly dense masses 
Clumpy, ill-defined aggregation of 
chromatin 
Biochemical Criteria 
Onset tightly regulated by physiological 
homeostasis 
Onset incidental to nonphysiological 
trauma 
Specific enzyme cascades for signal 
transduction and execution Enzyme cascades altered or inactive 
Metabolically viable during execution Non-viable during execution 
Macromolecules may be newly 
synthesized Macromolecules not synthesized 
Phosphatidylserine exposure signals 
death 
Nonspecific lytic effusion indicates 
death 
Nonrandom, oligonucleosomal 
fragment lengths (DNA ladder) 
Random DNA fragment lengths 
(DNA smear) 
 
Table 1.1. Distinction of morphological and biochemical features between 






Although apoptosis and necrosis are two alternative forms of cell death, under some 
circumstances, these two distinguishable forms of cell death can reciprocate. Since 
apoptosis requires energy, depletion of intracellular ATP has been shown to result in 
the switch from apoptosis to necrosis (Eguchi, Shimizu et al. 1997; Leist, Single et al. 
1997; Ha and Snyder 1999). Moreover, recent studies also proved that inhibition of 
caspase recruitment and activation, or prevention of mitochondrial cytochrome c 
release may block apoptosis, and thus promote necrosis (Kalai, Van Loo et al. 2002; 
Fortunato, Deng et al. 2006; Mareninova, Sung et al. 2006). Factors that dominate the 




















Fig. 1.1 Overview of cell-death signaling pathways, apoptosis vs. necrosis. 
Components in red inhibit apoptosis, whereas those in green promote apoptosis. 
Factors (in blue) such as mitochondrial permeability transition and reactive oxygen 
species (ROS) can cause either apoptosis or necrosis, depending on other variables 
such as ATP supply. FLIP, FLICE-like inhibitory protein; IAP, inhibitor of apoptosis 
proteins; Apaf, apoptotic protease activating factor; Cyt-c, cytochrome c; TNFR, TNF 





1.4.2 Mechanisms of apoptosis 
1.4.2.1 Caspase activation 
Caspases are specialized cysteine-dependent proteases that cleave major structural 
proteins of the cytoplasm and nucleus (Alnemri, Livingston et al. 1996; Thornberry, 
Rano et al. 1997).  These cysteine proteases share a series of common properties: they 
are all aspartate-specific cysteine proteases; they all have a conservative pentapeptide 
active site ‘QACXG’ (X can be R, Q or D); their precursors are all zymogens known 
as procaspases (Nicholson D. W. and Thornberry N. A. 1997). The N-terminal of the 
prodomain in procaspases contains a highly diverse structure, which is required for 
caspase activation (Nancy A. Thornberry et al. 1997). These structures are all capable 
of activating other caspases (Launay, Hermine et al. 2005). So far fourteen caspases 
have been identified. Based on their homology in amino acid sequences, caspases are 
divided into three subfamilies: (I) apoptosis activator/initiator- caspase-2, 8, 9 and 10; 
(II) apoptosis executioner/effector- caspase-3, 6 and 7; (III) inflammatory mediator- 
caspase- 1, 4, 5, 11, 12, 13, and 14. (Launay, Hermine et al. 2005) 
 
The activation of caspases can be detected almost in all apoptotic cells, regardless of 
their origin or the death stimulus (Thornberry, Rano et al. 1997). The proteolytic 
activity of the effector caspases such as caspase 3 is regarded as a hallmark of 
apoptotic cell death (Thornberry NA and Lazebnik Y, 1998). Activation of caspase 3 
results in the destruction of vital proteins and the death of the cell (Cohen GM. 1997). 
For instance, caspase 3-mediated cleavage causes destruction of macromolecular 
structures such as the laminin network, activation of pro-apoptotic proteins such as 
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caspase-activated DNase (CAD), which is responsible for apoptotic DNA 
fragmentation (Liu XS, Zou H, et al. 1997; Sakahira H, Enari M et al. 1998; Janicke 
RU, Sprengart ML et al. 1998; Kothakota S, Azuma T et al. 1997).  In addition, 
caspases activity is able to inactivate pro-necrotic proteins, such as polyADP-ribose 
polymerase (Hengartner 2000). Until now, no activation of caspases has been found 
in necrotic cell death. Furthermore, inactivation of caspases could switch apoptosis to 
necrosis (Fortunato, Deng et al. 2006; Mareninova, Sung et al. 2006). Therefore, the 
presence of caspase activation can be used as a criterion for distinguishing cellular 
apoptosis from necrosis.   
 
However, characterization of C. elegans ced-3 mutants revealed that apoptosis 
underwent even in the absence of ced-3 (Ellis, H. M. and Horvitz, H. R, 1986) which 
indicated that cell death can occur in the absence of caspase activation. Subsequent 
findings were consistent with the existence of ced-3-independent apoptosis (Shaham, 
S., Reddien P. W., et al. 1999). Some studies have suggested caspase-independent 
apoptosis in mammals (Chou, J. J., Li, H. et al. 1999; Cheng, E. H., Wei, M. C., et al. 
2001; Li, L. Y., . et al. 2001). Genetic studies on apoptosis induced by BH3-domain 
only proteins, such as tBid, Bim and Bad, showed that these proteins, which have 
been shown to promote caspase activation and apoptosis, can also kill cells 
independently of Apaf-1 and downstream caspases (Cheng, E. H., Wei, M. C., et al. 
2001). Specifically, Apaf-1-/- mouse embryonic fibroblasts (MEFs) could still die in 
response to the overexpression of BH3-domain-only proteins (Cheng, E. H., Wei, M. 
C., et al. 2001). Caspase activation was not detected in these dying cells when 
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assayed with fluorogenic substrates for caspase-2, -3, -6 or -7, nor could cell death be 
blocked by the pan-caspase inhibitor zVAD-fmk (Cheng, E. H., Wei, M. C., et al. 
2001). 
 
Also other mammalian mediators of caspase-independent apoptosis have been 
identified, such as apoptosis-inducing factor (AIF), a conserved mitochondrial 
oxidoreductase (Chou, J. J., Li, H. et al. 1999),  and endonuclease G (Li, L. Y., . et al. 
2001). In the early mouse embryo, apoptosis occurs in the ectoderm to create the pro-
amniotic cavity. An in vitro model of this event uses an aggregate of embryonic stem 
(ES) cells in which the inner ectodermal cells undergo cell death (Chou, J. J., Li, H. et 
al. 1999). Both have been suggested to be capable of inducing apoptotic changes in 
the nucleus (i.e., DNA fragmentation), but neither have been demonstrated to be 
responsible for other stereotypical changes that occur in apoptosis (e.g., exposure of 
phosphatidylserine and proteolysis of vital substrates) (Chou, J. J., Li, H. et al. 1999; 
Li, L. Y.,  et al. 2001). 
 
Caspases are proteases, it is possible that caspase-independent cell death might 
require other proteases (Pennacchio, L. A., Bouley, D. M., et al. 1998; Mathiasen, I. 
S., Lademann, U., et al. 1999; Mathiasen, I. S., Sergeev, I. N., et al. 2002.) Indeed, 
there is a weak, yet suggestive evidence that might support roles for cathepsins, 
calpains and granzyme B in caspase-independent apoptosis (Pennacchio, L. A., 
Bouley, D. M., et al. 1998). Cathepsins are lysosomal proteases, and mice lacking 
cystatin B, an inhibitor of cathepsins B, H, L and S, show cerebellar cell death 
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(Pennacchio, L. A., Bouley, D. M., et al. 1998). This suggests that cathepsins might 
mediate cell death, although it is also possible that the phenotype was caused by a 
cathepsin-independent effect of cystatin B (Pennacchio, L. A., Bouley, D. M., et al. 
1998). Calpains are a family of calcium-dependent proteases that have also been 
described as possible facilitators of cell death (Mathiasen, I. S., Lademann, U., et al. 
1999; Mathiasen, I. S., Sergeev, I. N., et al. 2002). In breast cancer cells, vitamin-D-
induced cell death appeared to be caspase-independent (Mathiasen, I. S., Lademann, 
U., et al. 1999) and promoted by calpains (Mathiasen, I. S., Sergeev, I. N., et al. 
2002). 
 
1.4.2.2 Two caspase-dependent signaling pathways of apoptosis 
Generally, there are two caspase-dependent signaling pathways of apoptosis: one is 
the death receptor-mediated pathway; the other is the mitochondrion-mediated 
pathway (Scaffidi C, Fulda S, et al. 1998) (summarized in Fig. 1.1). Both pathways 
culminate in the activation of executioner caspases, which cleave key cellular 
substrates, leading to the execution of apoptosis (Chen and Goeddel 2002; Wajant 
2002; Newmeyer and Ferguson-Miller 2003). Although these two distinguishable 
pathways are independent of each other under most conditions, there is still 
considerable cross-talk between them in some circumstances (Kerr JF, Wyllie AH et 
al. 1972). The pathway that a cell takes for apoptosis depends on both of the cell type 
and the agent causing apoptosis (Bhatia, 2004).  
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1.4.2.2.1 Death receptor-mediated apoptotic pathway  
Death receptors are cell surface molecules belonging to a subset of the tumor necrosis 
factor receptor (TNFR) superfamily. Each of these receptors contains an extracellular 
cysteine-rich domain and an intracellular homologous motif called “death domain” 
(DD) (A.M. Chinnaiyan, K. O'Rourke et al. 1995). DD is a common motif for death 
receptors and it is essential for the transduction of death signal (Ashkenazi and Dixit 
1998; Pan, Bauer et al. 1998). Moreover, it is responsible for recruiting adaptor 
molecules which, in turn, recruit caspases to the receptor complex. This simple 
strategy greatly increases the probability of caspase activation by promoting the cross 
processing of caspases within the cluster (Muzio, Stockwell et al. 1998; Yang, Chang 
et al. 1998).  
 
Among all death receptors, Fas and TNFR-1 are best characterized. Fas and TNFR-1 
can recognize and bind their corresponding death signals Fas ligand (FasL) and tumor 
necrosis factor (TNF). FasL and TNF belong to the TNF superfamily of cytokines and 
exist as either a membrane-bound or a soluble protein (Itoh, Yonehara et al. 1991; 
Suda, Takahashi et al. 1993; Nagata 1997). The binding of Fas with FasL or TNF 
with TNFR-1 will in turn activate Fas and TNFR-1. Like other death recepotors, Fas 
and TNFR-1 also share DD, the homologous motif in the cytoplasmic tail (A.M. 
Chinnaiyan, K. O'Rourke et al. 1995). Upon activation, DD serves as a docking site 
for DD-containing adaptor proteins such as FADD (for Fas) and TRADD (for TNFR-
1) through homotypic DD interactions (H. Hsu, J. Xiong. et al. 1995). The triggered 
aggregation of FADD or TRADD emerges of death effector domains (DEDs) (Fan, 
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Han et al. 2005). The exposed DEDs then interact with the DEDs in the prodomain of 
procaspase-8, which is localized on the cytosolic side of the plasma membrane, and 
induces the oligomerization of procaspase-8. Thereby, a complex known as the death-
inducing signal complex (DISC) is formed (Vincenz and Dixit 1997). In DISC, two 
linear subunits of procaspase-8 are compact to each other followed by the 
autoactivation of caspase-8 (Martin DA, Siegel RM et al. 1998; Bhatia 2004a).  
 
The activation of the downstream pathways of caspase-8 varies with different cell 
types (Scaffidi, Fulda et al. 1998). In Type I cells (cells of some lymphoid cell lines), 
caspase-8 is vigorously activated and can directly activate the downstream 
procaspases (e.g. procaspase-3). In Type II cells (other than Type I cells), caspase-8 is 
only mildly activated and unable to activate procaspase-3 directly. However, it can 
activate the mitochondrion-mediated pathway by truncating Bid (a pro-apoptotic Bcl-
2 family member in the cytosol), into its active form, tBid. tBid will trigger the 
activation of the mitochondrion pathway: cytochrome c, apoptosis-inducing factor 
(AIF) and other molecules are released from mitochondria, leading to the initiation of 
apoptosis (Scaffidi, Fulda et al. 1998). 
 
1.4.2.2.2 Mitochondrion-mediated apoptotic pathway 
Cellular stress or loss of survival signals activates the death machinery and triggers 
apoptosis via mitochondrial pathway (Kroemer and Reed 2000; Ferri and Kroemer 
2001). The mitochondrion plays a central role in apoptosis by sequestering a number 
of pro-apoptotic proteins in its intermembrane space, including cytochrome c, 
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apoptosis inducing factor (AIF), second mitochondrial-derived activator of caspase 
(Smac)/ direct IAP-binding protein with low PI (DIABLO), endonuclease G (Endo G), 
and serine protease high temperature requirement protein A2 (Omi/HtrA) (Suzuki, 
Imai et al. 2001; Hegde, Srinivasula et al. 2002). The release of these proteins 
activates apoptotic events in the cytosol and nucleus. For instance, once being 
released, cytochrome c binds to apoptotic protease activating factor -1 (apaf-1) (Zou, 
Henzel et al. 1997) and induces the assembly of apoptosome. Apoptosome is a 
complex of cyt c, dATP, apaf-1 and pro-caspase-9, upon which caspase-9 is activated 
(Liu, Kim et al. 1996). Activated caspase-9, in turn, activates effector caspases such 
as caspase-3, -6, and -7, leading to final demolition of the cell (Slee, Adrain et al. 
1999).  
 
The release of sequestered pro-apoptotic molecules in mitochondria is critically 
regulated by Bcl-2 family proteins (Gross, McDonnell et al. 1999; Cory and Adams 
2002). Following death stimulus, pro-apoptotic Bcl-2 family proteins are activated 
and translocated to mitochondria, where they increase the mitochondrial membrane 
permeability by opening the mitochondrial permeability transition (MPT) pore to 
allow the release of pro-apoptotic molecules into cytosol (Kim, He et al. 2003; Crow, 
Mani et al. 2004).  
 
Bcl-2 family proteins share sequence conservation in one to four Bcl-2 homology 
(BH) domains. Based on their structure and functional similarities, the members can 
be divided into two groups. Group I proteins are anti-apoptotic proteins, including 
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A1/Bfl1, Bcl-2, Bcl-w, Bcl-xL, Boo/Diva, Mcl-1, NR-13 and Nrf3 in mammals, 
BHRF-1, E1B19K, Ks-Bcl-2, LMW5-HL plus ORF16 in bacteria, and Ced-9 in C. 
elegans (Gross, McDonnell et al. 1999; Milosevic, Hoffarth et al. 2003; Bhatia, 
Wong et al. 2005). They all have four short Bcl-2 homology (BH) domains: BH1, 
BH2, BH3 and BH4. Group II proteins are pro-apoptotic proteins, including Bad, Bak, 
Bax, Bcl-rambo, Bcl-xS, Bid, Bik, Bim, Blk, BNIP3, Bok/Mtd, Hrk and Nip3 in 
mammals, along with Egl-1 in C. elegans (Milosevic, Hoffarth et al. 2003).  
 
There is a third class of death effector molecules sharing homology only to the Bcl-2 
homology 3 (BH3) domain such as Bad, Bid, Bik, Bim, Bmf and Noxa, Puma, BNip. 
These molecules can activate pro-apoptotic Bcl-2 family members or inactivate anti-
apoptotic members (Wang, Yin et al. 1996; Bouillet and Strasser 2002; Chipuk JE, 
Kuwana T et al. 2004; Chen L, Willis SN et al. 2005; Kuwana T, Bouchier-Hayes L 
et al. 2005; Willis SN, Chen L et al. 2005; Walensky LD, Kung AL et al. 2004). 
 
Pro-and anti-apoptotic members of the Bcl-2 family can homodimerize or 
heterodimerize, leading to a large number of combinations within a cell. 
Heterodimerization between a pro-apoptotic member and an anti-apoptotic member 
may nullify the functions of each (Oltvai, Milliman et al. 1993; Sedlak, Oltvai et al. 
1995). It is generally believed that the ratio of pro-apoptotic to anti-apoptotic Bcl-2 
family members is critical in determining whether the cell will undergo apoptosis or 
survive (Oltvai, Milliman et al. 1993). 
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1.4.2.3 Phagocytosis of apoptotic cells 
Recognition and engulfment of apoptotic cells by phagocytes are crucial characters of 
apoptosis in vivo (Savill, Dransfield et al. 2002). When cells are undergoing apoptosis, 
they are beginning to display ‘eat me’ signals through expression of surface markers, 
which act as positive signals for recognition and engulfment by phagocytes (Pradhan 
D, Krahling S, et al. 1997; Shiratsuchi A, Umeda M et al. 1997; Hanayama R, 
Tanaka M. et al. 2002). Recognition and engulfment of apoptotic cells are mediated 
by a variety of phagocytic receptors and opsonins, which not only trigger engulfment 
but also regulate immune responses by up-regulating anti-inflammatory cytokines or 
down-regulating pro-inflammatory mediators (Fadok, Savill et al. 1992; Bzowska, 
Guzik et al. 2002; Ferlazzo, D'Agostino et al. 2003; Monks, Rosner et al. 2005; 
Stuart and Ezekowitz 2005) (summarized in Fig. 1.2). The mechanisms of 
phagocytosis depend on the means of induction of cell death, the type of phagocyte 
and apoptotic cell, as well as the surrounding microenvironment (Savill, Dransfield et 
al. 2002; de Almeida and Linden 2005).  
 
The current section will briefly review the most important molecules involved in 
apoptotic-cell clearance at first, and then discuss the anti-inflammatory effect of 
apoptotic-cells clearance by phagocytes. 
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1.4.2.3.1 Surface signals of apoptotic cells 
Unlike normal cells, apoptotic cells trigger expressions of a wide range of surface 
molecules to meet the recruitment of phagocytes (Pradhan D, Krahling S, et al. 1997; 
Shiratsuchi A, Umeda M et al. 1997; Hanayama R, Tanaka M. et al. 2002). Among 
the molecular legion, anionic phospholipid phosphatidylserine (PS) is best known as a 
primary ‘eat me’ signal (Fadok VA, Voelker DR. et al. 1992; Martin SJ, et al. 1995; 
Fadok VA, Savill JS et al. 1992). Normally, PS is sequestered on the inner layer of 
the plasma membrane (Neuenschwander PF, Fiore MM, et al. 1995). The 
maintenance of PS asymmetry in normal membrane is dependent on two mechanisms: 
(1) the action of the amiophospholipid translocase, a membrane protein, which 
transfers PS from the outer leaflet to the inner one (Fadok VA, Voelker DR. et al. 
1992; Zwaal RFA and Schroit AJ et al. 1997); (2) the tethering of PS to membrane 
skeletal proteins such as fodrin (Vanags DM, PornAres MI et al. 1996). However, 
during apoptosis, the maintenance of PS asymmetry is lost, and PS externalizes from 
inner leaflet to the cell surface making the apoptotic cell recognizable to phagocytes 
(Fadok VA, Voelker DR. et al. 1992; MARTIN SJ, et al. 1995; Fadok VA, Savill JS 
et al. 1992). The mechanisms for externalization of PS are not fully understood 
(Kagan VE, Borisenko GG. et al. 2003). It is believed that PS externalization is an 
active process, triggered by the activation of scramblase, a cell membrane protein 
responsible for transportation of phospholipids between the two leaflets of the lipid 
bilayer (Verhoven B, Schlegel RA, et al. 1995). Studies also indicated that the extent 
of PS externalization was modulated by the extent of amiophospholipid translocase 
impairment (Fadok VA, Voelker DR. et al. 1992; Zwaal RFA and Schroit AJ et al. 
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1997). In addition, cleavage of fodrin, caspase activation and p38 MAP kinase 
activation are all suggested to be involved in the mechanisms of PS externalization in 
apoptosis (Fadok, Bratton et al. 1998; de Almeida and Linden 2005).  
 
PS exposure is known to be a universal feature of apoptotic cells and this change is 
absolutely necessary for recognition and engulfment. Now it is clear that all 
phagocytes recognize PS on apoptotic cells (Fadok, Bratton et al. 2001). However, PS 
itself is not sufficient for triggering engulfment. Recent proteomics studies have 
identified annexin I, a PS binding protein, as a new recognition signal for tethering 
and internalization of apoptotic cells (Ferlazzo, D'Agostino et al. 2003). Moreover, 
the modified pattern of glycosylation and the oxidation of proteins or lipids at the 
apoptotic cell surface are also important for engulfment (Henson, Bratton et al. 2001). 
 
1.4.2.3.2 Phagocytic receptors  
A series of receptors presenting on the surface of phagocytes have been identified to 
mediate the interaction between apoptotic cells and phagocytes. PS receptor (PSR) is 
a newly defined PS-stereospecific receptor, which recognize PS on apoptotic cells 
and is widely expressed in diverse tissue and cells (Fadok, Bratton et al. 2000). The 
interaction between PS and PSR results in tethering of dying cells. Series of in vitro 
studies have shown that blocking PSR prevented most apoptotic cell uptake, which 
indicates that PSR appears to be essential for phagocytosis of apoptotic cell (Henson, 
Bratton et al. 2001).  
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However, due to the low affinity for PS, individual PSR molecules are not enough for 
insuring the tethering process. Indeed, multiple receptors are implicated in 
phagocytosis of apoptotic cells such as CD36. CD36 is a prototypic member of the 
scavenger receptor B family (Endemann, Stanton et al. 1993). It is widely expressed 
on the surface of multiple cell types such as macrophages, endothelial cells, etc 
(Fadok, Warner et al. 1998). Many in vitro studies have demonstrated that expression 
of CD36 on the surface of cells confers phagocytic activity on those cells by 
recognizing oxidized sites on apoptotic cells (Fadok, Warner et al. 1998; Ren, 
Silverstein, et al. 1995; Albert, Pearce et al. 1998). This suggests a role for CD36 
scavenger receptor in the recognition of apoptotic cells. However, in spite of these 
demonstrations in vitro, as yet there is no direct evidence of CD36 involvement in 
apoptotic cell clearance in vivo. 
 
Besides CD36, many other PS non-specific binding receptors have been reported to 
be involved in recognition of dying cell, such as scavenger receptors (e.g. scavenger 
receptor A, LOX-1, etc), vitronectin receptors (e.g. integrin αvβ3, integrin αvβ5, etc), 
receptor tyrosine kinase MER, CD91 and surfactant protein A (Fadok, de Cathelineau 
et al. 2001). These receptors together with additional bridging molecules (e.g. β2GP1, 
gas-6, etc) (Fadok VA, Bratton DL et al. 1998) not only bind to PS, but also bind 
other ligands that may arise on the surface of apoptotic cells.  
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1.4.2.3.3 The anti-inflammatory effect of apoptotic-cells clearance 
Apoptotic-cell clearance has long been regarded as a passive phenomenon with the 
only purpose of maintaining homeostasis in the body, keeping silence to the immune 
system. However, recent studies have shown that this natural process not only has 
non-inflammatory effect but also suppress inflammation or even set up an active 
regulation of inflammation (Majai, Petrovski et al. 2006). Although the exact 
signaling mechanisms that determine the inflammatory effect of apoptotic-cells 
clearance are as yet to be understood, there are several possible explanations 
elucidated by recent literature.  
 
First, unlike necrotic cells, apoptotic cells maintain their membrane integrity all along 
before phagocytosis. Therefore, leakage of intracellular components such as pro-
inflammatory and immunogenic materials is prevented during the apoptosis. 
Therefore, the membrane integrity prevents apoptotic cells promoting inflammatory 
responses. The biochemical mechanisms of apoptotic cell membrane integrity are still 
largely unknown. Recent studies demonstrated that tTG (tissue transglutanminase)-
catalyzed intracellular protein cross-linking plays an important role in increasing the 
stability of apoptotic bodies and the consequent reduction of leakage of their contents. 
The association between apoptosis and the tTG activation was observed both in vivo 
and in vitro (Piredda, Amendola et al. 1997; Majai, Petrovski et al. 2006).  
 
Second, the process of actively suppressing inflammation is mainly through the 
production of anti-inflammatory mediators by apopto-phagocytic system. A 
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convincing body of evidence shows that phagocytes not only phagocytize apoptotic 
cells, but also respond to apoptotic cell death by up-regulating anti-inflammatory 
mediators such as TGF-β1 and IL-10, or down-regulating pro-inflammatory cytokines 
such as TNF-α and IL-1β (Bzowska, Guzik et al. 2002). It has been suggested that the 
appearance of PS on the surface of apoptotic cells and the recognition of PS by PSR 
positive macrophages may play an important role in the release of TGF-β1 (Fadok, 
Savill et al. 1992; Monks, Rosner et al. 2005). Besides PSR, PS-PSR bridging protein 
such as TSP1, PS non-specific binding receptors such as CD36, and vitronectin 
receptor, also have been reported to suppress monocyte/macrophage inflammatory 
responses by stimulating TGF-β1 release (Voll, Herrmann et al. 1997; Freire-de-Lima, 
Nascimento et al. 2000).  In addition, Annexin I, a newly defined endogenous 
molecules for tethering and internalization of apoptotic cells, can stimulate IL-10 
production and inhibit nitric oxide synthesis. This could provide a possible 
mechanism whereby IL-10 is secreted by mononuclear phagocytes engaging with 
apoptotic cells in annexin I-dependent manner (Ferlazzo, D'Agostino et al. 2003).  
 
Not only do the phagocytes release anti-inflammatory cytokines, but also the cells 
undergoing apoptosis. Apoptotic cells may themselves produce anti-inflammatory 
factors such as IL-10 (Tomimori Y, Ikawa Y, et al. 2000; Bzowska M, Guzik K et al. 
2002) and TGF-β (Hodge S, Hodge G et al. 2002). The persistent appearance of 
apoptotic cells in inflamed tissues could provide a prolonged anti-inflammatory 
stimulus and help to inhibit long term tissue damage (Majai, Petrovski et al. 2006). 
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Third, the direct suppression of proinflammatory responses may be due to the ligation 
between phagocytes and apoptotic cells. For instance, the engagement of some 
receptors on phagocytes by ligation to corresponding ligands on apoptotic cells has 
been shown to limit the magnitude and extent of macrophage activation. Thereby, the 
ligation itself may inhibit proinflammatory macrophage responses. Such phagocytotic 
receptors include Src homology 2 domain-bearing protein tyrosine phosphatase 
substrate-1 (SHPS-1), and tyro 3 family receptors etc (Oshima, Ruhul Amin et al. 



















Fig. 1.2. Phagocytosis of apoptotic cells results in anti-inflammatory signals 
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1.4.3 Mechanisms of apoptosis in acute pancreatitis 
The mechanisms of pancreatic acinar cell apoptosis in acute pancreatitis are as yet 
undefined (Wallig, Gould et al. 1988; Wallig, Kore et al. 1992; Bhatia, Wallig et al. 
1998; Gerasimenko, Gerasimenko et al. 2002; Gukovskaya, Gukovsky et al. 2002). 
The extent of pancreatic acinar cell apoptosis has been shown to be inversely related 
to the severity of the disease, suggesting that apoptosis is a teleologically beneficial 
form of cell death in acute pancreatitis (Kaiser, Saluja et al. 1995; Gukovskaya, 
Perkins et al. 1996; Bhatia 2004). Indeed, in animal models, induction of apoptosis 
has been found to have a protective action against acute pancreatitis (Bhatia, Wallig 
et al. 1998; Frossard, Rubbia-Brandt et al. 2003). It is, therefore, reasonable to 
speculate that selective induction of pancreatic acinar cell apoptosis may be of value 
in clinical acute pancreatitis. For example, the effect of prophylactic induction of 
apoptosis in individuals with a high risk of pancreatitis (such as those undergoing 
endoscopic retrograde cholangiopancreatography) should be investigated (Bhatia, 
2004). However, more basic research into the mechanisms of apoptosis of pancreatic 
acinar cells and how it benefits against acute pancreatitis is needed before one could 
take these studies into the clinic.  
 
1.4.3.1 Mechanisms of apoptosis arising from acute pancreatitis 
1.4.3.1.1 Caspase activation  
In both in vivo and in vitro experimental acute pancreatitis, the activation of caspase 
has been observed (Gerasimenko, Gerasimenko et al. 2002; Gukovskaya, Gukovsky 
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et al. 2002; Gukovsky, Reyes et al. 2003). Stimulation of isolated rat pancreatic acini 
with cholecystokinin, which serves as a model for human acute edematous 
pancreatitis in vitro, induces death-signaling pathways in rat pancreatic acinar cells, 
including caspase activation, cytochrome c release, and mitochondrial depolarization. 
The mitochondrial dysfunction is mediated by upstream caspase(s). Besides 
cholecystokinin, some major pathogenic factors in acute pancreatitis, such as 
oxidative stress, has also been shown to induce apoptosis of acinar cells involving 
activation of caspase-3, the executioner caspase in apoptosis (Song, Lim et al. 2003).  
 
In addition to mediating apoptosis, caspases also regulate other events in acinar cells, 
which have been shown to play key roles in acute pancreatitis. For instance, caspase 8, 
the initiator caspase, has been suggested to mediate the degradation of plectin, which 
is a critical biochemical event in secretory blockade and cell injury during 
cholecystokinin-induced acute pancreatitis (Beil, Leser et al. 2002). Moreover, 
caspases has been domenstrated to down regulate the intra-acinar cell activation of 
trypsin, which is a crucial initiating event in acute pancreatitis (Gukovskaya, 
Gukovsky et al. 2002). Particularly, caspases may negatively regulate necrosis 
through degradation of receptor-interacting protein (RIP), a key mediator of 
"programmed" necrosis and thus protect acinar cells from necrosis in pancreatitis 
(Gukovskaya, Gukovsky et al. 2002; Song, Lim et al. 2003; Mareninova, Sung et al. 
2006). This may help to explain why severity of acute pancreatitis was inversely 
related to the extent of pancreatic acinar cell apoptosis but not necrosis. 
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1.4.3.1.2 Apoptosis associated genes 
Apoptosis associated genes have been found to be involved in experimental acute 
pancreatitis. Gomez et al. ever showed that mRNA levels of both pro and anti-
apoptotic genes were simultaneously modified in acute pancreatitis. In their study, 
pancreatic mRNA levels of anti-apoptotic protein such as Bcl-xL and pro-apoptotic 
proteins such as Bax and p53 were significantly increased in a temporal fashion 
during induction of acute pancreatitis (Gomez, Lee et al. 2001). However, in the 
enhanced severe acute pancreatitis model, pancreatic expression of Bax and Bcl-2 
remains unchanged. It is possible that in that much severe model, pancreatic acinar 
cells may become unresponsive to apoptotic stimuli  (Frossard, Rubbia-Brandt et al. 
2003).  
 
Besides above apoptosis associated genes, a stress-inducible protein (SIP) has been 
identified as a new pro-apoptotic gene in pancreatic acinar cells recently (Tomasin R, 
Samir AA et al. 2001; Tomasin R, Samir AA et al. 2002). The expression of SIP was 
shown to be localized in pancreatic acinar cells (Savkovic V, Gaiser S et al. 2004). 
Studies demonstrated that SIP was overexpressed during acute pancreatitis (Tomasini, 
Samir et al. 2001). 
 
1.4.3.1.3 Neutrophils  
Neutrophil activation is an important determinant of severity of acute pancreatitis. 
Recent studies suggest that resolution of inflammatory responses in acute pancreatitis 
could be dependent on neutrophil apoptosis (O'Neill, O'Neill et al. 2000; Salomone, 
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Tosi et al. 2002). However, the infiltration of neutrophils may itself contribute to 
regulate pancreatic acinar cell death in acute pancreatitis (Rau, Paszkowski et al. 
2001). It has been suggested that neutrophils might play an anti-apoptotic role in 
acute pancreatitis (Fujimoto, Hosotani et al. 1997). The depletion of neutrophils by 
administration of anti-neutrophil serum or using ICAM-1 neutralizing antibody, 
results in a significant increase of apoptotic acinar cell numbers on one hand, and 
significantly decrease of necrotic acinar cell numbers on the other hand (Fujimoto, 
Hosotani et al. 1997). Yet in the experimental model of taurocholate-induced severe 
acute pancreatitis, neutrophils were demonstrated to be involved in the development 
of both apoptotic and necrotic forms of acinar cell death via a TNF-α-dependent 
mechanism (Rau, Paszkowski et al. 2001). 
 
1.4.3.1.4 Cytokines  
Cytokines are known to play a major role in the induction of inflammation. However, 
some pro-inflammatory cytokines such as TNF-α can be produced by pancreatic 
acinar cells (Gukovskaya, Gukovsky et al. 1997). Moreover, it has been demonstrated 
that  TNF-α is able to mediate apoptosis of pancreatic acinar cells both in vitro and in 
vivo (Gukovskaya, Gukovsky et al. 1997; Satoh, Gukovskaya et al. 2005). Other 
cytokines, such as IL-6, which plays a role in the initiating inflammation during 
severe acute pancreatitis, has been shown to prevent apoptosis of pancreatic acinar 
cells in acute pancreatitis (Chao, Chao et al. 2006). That study demonstrated that IL-6 
promotes activation of STAT-3, a transcription factor which down regulates cell 
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apoptosis. Therefore, blocking IL-6 increases apoptosis of pancreatic acinar cells and 
thereby attenuates the severity of severe acute pancreatitis. 
 
1.4.3.2 Induction of apoptosis in pancreatic acinar cells by compounds that do 
not cause acute pancreatitis  
Induction of apoptosis in pancreatic acinar cell by CCK has been well established 
(Gukovskaya, Gukovsky et al. 2002; Gukovsky, Reyes et al. 2003). However, it is 
known that CCK induces experimental acute pancreatitis both in vivo and in vitro. 
Therefore, it would be difficult to determine the exact role of apoptosis in CCK-
induced acute pancreatitis. Indeed, some compounds have been shown to induce 
apoptosis of pancreatic acinar cell but do not cause acute pancreatitis. Examples of 
these compounds are menadione (Gerasimenko, Gerasimenko et al. 2002) and 
crambene (1-cyano-2-hydroxy-3-butene-CHB) (Bhatia, Wallig et al. 1998). 
 
1.4.3.2.1 Induction of apoptosis in pancreatic acinar cell by menadione 
Menadione is a quinone that is metabolized by flavoprotein reductase to semiquinone, 
which can be oxidized back to quinone in the presence of molecular oxygen. In this 
redox cycle, superoxide anion radical, hydrogen peroxide and other reactive oxygen 
species are generated (Monks, Hanzlik et al. 1992). Menadione has been shown to 
elevate levels of cytosolic Ca2+, which is believed to cause cell death (Monks, 
Hanzlik et al. 1992). In a recent study, menadione has been shown to evoke repetitive 
cytosolic Ca2+ spikes, partial mitochondrial depolarization, cytochrome c release and 
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apoptosis of pancreatic acinar cells in vitro (Sherwood, Prior et al. 2007). As yet there 
are no studies reporting its in vivo effect in either cell death or in acute pancreatitis. 
 
1.4.3.2.2 Induction of apoptosis in pancreatic acinar cell by crambene 
Crambene, also known as cyanohydorxybutene (CHB), is a stable plant nitrile which 
can be found in many cruciferous vegetables rich in gulcosinolates. Gulcosinolates 
and their breakdown products are known to be toxic to stock animals in large 
quantities since 1953 (Kelly, Reid et al. 1999). As one of the breakdown products 
from gulcosinolates, crambene has been reported for its toxicity in rodents for a long 
time. In 1980, Nishe and Daxenbicher found that the LD50 of crambene in rats is 
200mg/kg (Kelly, Reid et al. 1999). At such high dose, crambene shows its toxicity in 
different organs with different ways of administration. When administered 
subcutaneously, 200mg/kg dosage of crambene causes liver necrosis and thyroid 
hyperplasia. When given orally in the same dose, it shows pancreatotoxicity, which is 
characterized by variable edema, acinar cell vacuolation, acinar cell death, and 
depletion of zymogen granules (Wallig, Gould et al. 1988; Maher, Chernenko et al. 
1991).  
 
However, at lower doses, crambene shows exclusive induction of acinar cell 
apoptosis in rodents. Wallig et al. noted that giving rats a single intravenous dose of 
50mg/kg could induce extensive apoptosis of pancreatic acinar cells (Wallig, Gould et 
al. 1988; Wallig, Kore et al. 1992).  In the subsequent study, Bhatia et al. have shown 
that administration of a single intravenous dose of 70mg/kg to mice induces the 
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apoptosis of pancreatic acinar cells. They have demonstrated that crambene 
administration causes extensive and time-dependent numbers of acinar cell apoptosis, 
which is maximal 12-24 hours after crambene administration (Bhatia, Wallig et al. 
1998). Moreover, induction of apoptosis in pancreatic acinar cells with crambene 
protects mice against caerulein-induced acute pancreatitis (Bhatia, Wallig et al. 1998). 
The maximal protective effect of crambene against acute pancreatitis is observed 
when the pancreatic acinar cells have become committed to apoptosis maximally 
(Bhatia, Wallig et al. 1998). This is despite the fact that crambene does not alter the 
interaction of CCK to its receptor on pancreatic acinar cells (Bhatia, Wallig et al. 
1998). Therefore, crambene seems to be an ideal apoptotic inducer to study the 
protective effect of apoptosis in caerulein-induced experimental acute pancreatitis. 
 
However, studies on the mechanisms of crambene-induced apoptosis are far from  
adequate. One study showed 5 mM crambene causes cell cycle arresting in Hep G2 
cells and G2/M phase in colonic adenocarcinoma cells (Keck, Staack et al. 2002). No 
study to-date has investigated the effect of crambene on isolated pancreatic acinar cell. 
Moreover, few studies contribute to the mechanism by which crambene-induced 
apoptosis protects against mouse acute pancreatitis. Recently, a possible role of the 
gap junction communication (GJC) and connexin gene Cx32 has been identified in 
acute pancreatitis (Frossard, Rubbia-Brandt et al. 2003). Mice deficient in Cx32 gene 
were found to be resistant to apoptosis induced by crambene and were more 
susceptible to acute pancreatitis than their wild-type counterparts (Frossard, Rubbia-
Brandt et al. 2003). That study also suggests a role of GJC in acinar cell apoptosis. 
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The study demonstrated that defective GJC in Cx32-deficient mice prevented acinar 
cell apoptosis at a step upstream of caspase-3 activation. At present, that is the only 
study investigating the mechanism by which crambene-induced apoptosis protects 
against mouse acute pancreatitis.  
 
1.5 Research questions and aims 
The mechanisms of pancreatic acinar apoptosis in acute pancreatitis are just 
beginning to be identified. The extent of acinar cell apoptosis has been shown to be 
inversely related to the severity of the disease, suggesting that apoptosis is a 
teleologically beneficial form of cell death in acute pancreatitis. Indeed, in an 
experimental setting, induction of apoptosis by the plant nitrile crambene has been 
shown to elicit the protective effect against acute pancreatitis. However, the induction 
of apoptosis by crambene in pancreatic acinar cells has only been investigated in vivo. 
Also, little is known about the mechanism by which crambene induces apoptosis in 
pancreatic acinar cell.  
 
Similarly, the exact mechanism by which the induction of apoptosis by crambene 
protects against acute pancreatitis is still not clear. Since apoptotic-cell clearance may 
have an anti-inflammatory effect, it is reasonable to postulate that phagocytosis with 
its anti-inflammatory character would play an important role as the possible 




Therefore, this study aimed to investigate the mechanism(s) by which crambene 
causes apoptosis of pancreatic acinar cells and the mechanism(s) through which 
induction of apoptosis in pancreatic acinar cells by crambene treatment protects 
against acute pancreatitis.  
 
In order to study the mechanism of apoptosis, we used primary pancreatic acinar cells 
as the experimental system. This is an ideal system to investigate the mechanism of 
apoptosis induced by crambene. Unlike the in vivo system, this in vitro system doses 
not involve many extraneous uncontrolled factors. In addition, unlike transformed cell 
lines, these primary pancreatic acinar cells are well preserved with most original 
characters of normal pancreatic acini.  
 
In order to explore the mechanisms why the induction of acinar cell apoptosis by 
crambene protects against acute pancreatitis, we utilized the mouse caerulein model 
of acute pancreatitis. This is because this model represents a simple, non-invasive and 
highly reproducible method of inducing severe pancreatitis. Moreover, it is in this 
model that the protective effect of crambene against acute pancreatitis was first 
observed. 
 
Specifically, the present study is intended to accomplish the above aims through 
investigating:  
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1. the pro-apoptotic effect of crambene on mouse pancreatic acinar cells in vitro and 
the possible apoptotic pathway(s) activated by crambene in pancreatic acinar cells; 
and 
2. the role of phagocytic clearance of apoptotic acinar cells in crambene-mediated 
protection against acute pancreatitis. 
 
This study helps define the mechanism of apoptosis in pancreatic acinar cells and the 
mechanisms by which induction of apoptosis in pancreatic acinar cells protects 
against acute pancreatitis.  Interventions that cause pancreatic cell apoptosis are likely 
to be of prophylactic, and possibly therapeutic value. Therefore, the achievement of 
this study may be useful in clinical management in patients with acute pancreatitis. In 
the long term, research on pancreatic acinar cell apoptosis may help us design new 











CHAPTER 2: MECHANISM OF CRAMBENE INDUCED 
APOPTOSIS IN ISOLATED PANCREATIC ACINAR CELLS 
2.1 Materials and methods  
2.1.1 Animals   
All experimental procedures were performed in accordance with the Guide for the 
Care and Use of Laboratory Animal (NIH Publication, 1996) and approved by the 
animal ethics committee of National University of Singapore.  
 
Adult male Swiss mice weighting 25-30g were purchased from Laboratory Animal 
Centre, Singapore. Mice were housed in a controlled environment with an ambient 
temperature of 22~26oC and a 12 h light/dark cycle. They were fed with standard 
laboratory chow and given water ad libitum.  
 
2.1.2 Crambene  
Crambene was kindly provided by Dr. Matthew Wallig. According to the methods 
provided by Dr. Matthew Wallig, crambene was isolated from autolysed crambe meal 
using immiscible solvent extraction followed by high-performance liquid 
chromatography (Wallig, Gould et al. 1988). Crambene purified by this method has 
been reported to be more than 99.5 % pure.  
 
 48
2.1.3 Preparation of pancreatic acini  
Mouse primary pancreatic acini were prepared by a previous established method of 
collagenase digestions (Wallig, Gould et al. 1988; Wallig, Kore et al. 1992; Bhatia, 
Wallig et al. 1998; Gerasimenko, Gerasimenko et al. 2002; Gukovskaya, Gukovsky 
et al. 2002). Briefly, pancreata from mice were infused with buffer A (140 mM NaCl, 
4.7 mM KCl, 1.13 mM MgCl2, 1 mM CaCl2, 10 mM glucose, 10 mM Hepes, pH 7.2) 
containing 200 IU/ml collagenase using 29G syringes, minced with a sharp tip 
surgical scissors till a fine suspension was achieved, and incubated for 10 minutes at 
370C in a shaking water bath. The digested tissue was passed through buffer A 
containing 50 mg/ml BSA, and washed twice with buffer A for further experiments. 
Cell viability was determined by trypan blue exclusion. Briefly, dropped 20 µl acinar 
cells suspension on a clean glass slide and added with 20 µl 0.4% of trypan blue dye. 
After covered with a coverslip, the viability was checked under light microscope. 
Futher experiments were carried out only when viability of the cells was more than 
95%. 
2.1.4 Induction of apoptosis in pancreatic acinar cells 
The prepared acini were distributed into microfuge tubes (around 1× 105 -1× 106 
pancreatic acinar cells per tube) containing buffer A using a micropipette. Crambene 
was added into these tubes with the varying working concentration of 0.2mM, 2mM 
and 20mM respectively. Acini were incubated with or without crambene at 370C in a 
shaker water bath for 1 hour, 2 hours, 2.5hours, 3 hours, 3.5 hours, 4 hours, 4.5hours 
 49
and 6 hours respectively. In some experiments, caspase inhibitors were used together 
with crambene treatment.  
 
2.1.5 Annexin V-FITC/propidium iodide staining detection  
Extent of apoptosis and necrosis was determined by annexin V-FITC/propidium 
iodide staining using BD ApoAlertTM annexin V-FITC apoptosis Kit. After treatment 
with 2 mM crambene, pancreatic acinar cells were rinsed with 200µl 1× binding 
buffer twice. Cells were centrifuged 10 minutes at 200× g at 4°C and the supernatant 
removed. After resuspending in 200µl 1× binding buffer, cell suspension was added 
with 5 µl annexin V (20 µg/ml in Tris-NaCl) and 5 µl Propidium Iodide (50 µg/ml in 
1× binding buffer), and incubated at room temperature for 15 min in the dark. After 
washing with 2ml 1× assay buffer to each tube for two times, cells were centrifuged 
10 minutes at 200× g at 4°C and then resuspended in 0.5ml of 1× binding buffer using 
a micro pipette to disrupt cell-to-cell clumping. 
 
For fluorescence microscopy analysis, 50µl cell suspension was placed on a clean 
glass slide and covered with a glass coverslip. Cells were observed by fluorescence 
microscopy (Carl Zeiss) using a “dual-band pass” filter designed to simultaneously 
detect fluorescein (excitation 490 nm, emission 520 nm) and rhodamine (excitation 
540 nm, emission 570 nm). The cells showing visible annexin V staining (with no PI 
staining) were categorized as apoptotic cells.  
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For spectrofluorometer analysis, 100µl cell suspension from each sample was 
collected and placed a well of a 96-well black, flat bottom plate. Then the plate was 
read by Gemini EM Microplate Spectrofluorometer measuring red fluorescence 
(excitation 535 nm, emission 617 nm) and green fluorescence (excitation 488 nm, 
emission 530 nm). In some experiments, caspase inhibitors were used together with 
crambene treatment.  
 
2.1.6 Caspase assay  
Caspase assay was carried out according to the manufacturer’s protocol (Bio-Rad 
Laboratories). Caspase 3, 8 and 9 enzyme activation were quantified using a 
fluorometric assay by measuring the extent of cleavage of enzyme-specific 
fluorometric peptide as previously described (Talanian, Quinlan et al. 1997; 
Thornberry, Rosen et al. 1997; Stennicke and Salvesen 2000)  
 
After crambene treatment, the incubated cells were centrifuged to obtain a cell pellet 
which is then immersed with 100µl lysis buffer (BD PharMingen Technical), which 
composed of 10mM Tris-HCl, 10mM NaHPO4, 130 mM NaCl, 1% Triton-X-100 and 
10mM sodium pyrophosphate) with extra 1mM Phenylmethylsulfonyl Fluoride 
(PMSF), 0.005mg/ml aprotinin, 0.005 mg/ml pepstatin A, and 0.01mg/ml levpeptin. 
Afterwards, freeze and thaw steps were carried out three times by transferring from 
liquid nitrogen to a 370C water bath. The lysed cells were centrifuged at 40C for 30 
minutes at 13000 rpm. 50µl supernatant from each sample was collected and placed a 
well of a 96-well black, flat bottom plate. Then immediately added with fluorometric 
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substrate for caspase3 (Ac-DEVD-AFC- BD PharMingen), caspase 8 (Ac-IETD-
AFC- BD PharMingen) and caspase 9 (Ac-LEHD-AFC -Calbiochem) respectively, 
which was freshly dissolved in the 50µl reaction buffer (10mM HEPES, 2mM EDTA, 
0.1% CHAPS and 5mM DTT, Bio-Rad) with the final working concentration at 
0.04µg/µl in total volume of 100µl in each well.  
 
The fluorescence of cleaved substrates was determined at respective wavelength 
(excitation 394 nm, emission 535 nm for caspase 3, excitation 400 nm, emission 505 
nm for caspase 8 and 9) using a fluorescence plate reader (TECAN, USA) every 5 
min interval for 75 minutes at 370C. The specific caspase activation was determined 
from the rate of fluorescence change with time, in which the basal level of 
fluorescence was deducted (Bio-Rad). The comparison of caspase activation among 
groups was made using the respective rate values (∆S/∆t). Caspase activation was 
expressed as relative fluorescent unit per hour per µg DNA per µl as calculated using 
the linear range of the assay (Timothy A. McCaffrey, et al. 1988; Otto WR, 2005). 
The caspase activation in untreated cells was considered to be 1.  
 
For caspase inhibitor assays, caspase-3-specific inhibitor Z-DEVD-FMK, caspase-8-
specific inhibitor Z-IETD-FMK and caspase-9-specific inhibitor Z-LEHD-FMK 
(R&D systems, USA) were used at the working concentration of 100 µM according to 
manufacturer’s instructions (Miyazaki K, Yoshida H et al. 2001).  
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2.1.7 Mitochondrial membrane potential detection  
The mitochondrial membrane potential in acinar cells was detected by BD™ 
MitoScreen Mitochondrial Membrane Potential Detection Kit containing JC-1 
(5,5’,6,6’-tetrachloro-1,1’,3,3’-tetraethylbenzimidazolylcarbocyanineiodide).  
 
Briefly, after treatment with 2 mM crambene, pancreatic acinar cells were centrifuged 
at 400g for 5 minutes at room temperature and subsequently carefully removed and 
discarded the supernatant. Cells were then incubated in JC-1 working solution for 15 
minutes at 370C water bath. After washing with 2ml 1× assay buffer to each tube for 
two times, cells were centrifuged at 400g for 5 minutes and then resuspended in 0.5ml 
of 1× assay buffer using a micro pipette to disrupt cell-to-cell clumping. 
 
For fluorescence microscopy analysis, 50µl cell suspension was placed on a clean 
glass slide and covered with a glass coverslip. Changes in mitochondrial membrane 
potential (∆Ψm) were assessed by fluorescence microscopy (Carl Zeiss) using a 
“dual-band pass” filter designed to simultaneously detect fluorescein (excitation 490 
nm, emission 520 nm) and rhodamine (excitation 540 nm, emission 570 nm). The 
fluorescence emission spectrum of JC-1 is dependent on its states (monomers and 
aggregates) that, in turn, are determined by the status of the ∆Ψm (Cossarizza, A., M. 
Baccarani-Contri, et al. 1993). With polarized ∆Ψm of normal cells, JC-1 formats 
aggregates in mitochondria resulting in higher levels of red fluorescence emission, 
whereas with depolarized ∆Ψm of apoptotic cells, JC-1 does not accumulate in 
mitochondria and remains in the cytoplasm as monomers resulting in higher levels of 
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green fluorescence emission. Therefore, with JC-1 staining, polarized mitochondria 
in normal cells are visualized by punctuated red staining, whereas depolarized 
mitochondria in apoptotic cells are visualized by their diffuse green staining. 
 
For spectrofluorometer analysis, 100µl cell suspension from each sample was 
collected and placed a well of a 96-well black, flat bottom plate. Then the plate was 
read by Gemini EM Microplate Spectrofluorometer measuring red fluorescence 
(excitation 550 nm, emission 600 nm) and green fluorescence (excitation 485 nm, 
emission 535 nm). Data were expressed as cell retention of JC-1 (Relative ratio of red 
to green fluorescence). The level of JC-1 retained by untreated cells at 3 hours was 
considered to be 1. In some experiments, caspase inhibitors were used together with 
crambene treatment. 
 
2.1.8 Measurement of cytochrome c release from mitochondria  
After treatment with 2 mM crambene for 3 hours, acinar cells were washed in fresh 
isolation buffer (20 mM Hepes, 10 mM KCl, 1.5 mM MgCl2, 1 mM EDTA, 1 mM 
EGTA, 1 mM DTT, 250 mM sucrose pH 7.5) and homogenized in a 7 ml glass tissue 
douncer using up and down strokes of pestle. The homogenate was centrifuged at 800 
×g, 10 min at 4oC and then the supernatant was retained and centrifuged at 10,000 ×g, 
10 min at 4oC. Pellet was washed twice and resuspended in wash buffer (210 mM 




Cytochrome c release from isolated mitochondria in acinar cells was then measured 
by cytochrome c DuoSet IC ELISA kit (R & D Systems). Briefly, cytochrome c 
primary antibody was aliquoted onto ELISA plates and incubated at 4°C overnight. 
Wells for standards were added with series dilution of cytochrome c control. Wells 
for total mitochondrial cytochrome c samples, which are defined as the amount of 
cytochrome c detected in lysed mitochondria, were added with 0.1% Triton X-100 
first. Then all the wells were added with the freshly prepared horseradish peroxidase 
conjugated cytochrome c detection antibody in addition of 100µg/ml leupeptin, 100 
µg/ml pepstatin A, 16µg/ml aprotinin, and 400µM PMSF. Subsequently, 
mitochondrion suspension from both treated and untreated cells were immediately 
added into the appropriate wells followed by 30 minutes incubation at 30°C. After 
vigorous washing for 5 times, tetramethylbenzidine was added for color development 
for 6 minutes at room temperature, and the reaction was terminated with 2 M H2SO4. 
Absorbance was measured at 450 nm with the reference wavelength at 540 nm 
(TECAN, USA).  
 
Results were adjusted by total cytochrome c in mitochondria. The level of released 
cytochrome c determined in untreated cells at 3 hours was considered to be 1. Data 
were expressed as fold increase over control.  
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2.1.9 TNF-α and Fas ligand assay 
Pancreatic acinar cell supernatants were assayed for TNF-α and Fas ligand using a 
sandwich ELISA, according to the manufacturer's instructions (Duoset kit; R&D 
Systems, Minneapolis, MN). Briefly, after treatment with 2 mM crambene, the acini 
were centrifuged at 40C for 2 minutes at 2000 rpm. The supernatant was used for the 
assay. Anti- TNF-α or anti- Fas ligand primary antibody was aliquoted onto ELISA 
plates and incubated at 4°C overnight. Samples and standards were incubated for 2 h, 
the plates were washed, and a biotinylated anti- TNF-α or anti- Fas ligand antibody 
was added for 2 h. Plates were washed again, and streptavidin bound to horseradish 
peroxidase was added for 20 min. After a further wash, tetramethylbenzidine was 
added for color development, and the reaction was terminated with 2 M H2SO4. 
Absorbance was measured at 450 nm. 
 
2.1.10 Statistical analysis 
All experiments were repeated at least three times with samples triplicated. Results 
are expressed as mean ± SE. Treatment effects were compared using Student's t test 
or one-way ANOVA followed by a post hoc analysis (Tukey test). A P-value of less 




2.2.1 Crambene stimulates an increase of annexin-V binding 
Among the surface changes, the most common and best characterized in apoptotic 
cells is the loss of phospholipids asymmetry in the plasma membrane and the 
translocation of phosphatidylserine from the inner to the outer leaflet of the lipid 
bilayer (Fadok, Savill et al. 1992; Hoffmann, deCathelineau et al. 2001; Schlegel and 
Williamson 2001). The exposure of phosphatidylserine occurs very early during the 
apoptotic process and is almost universally required for engulfment (Fadok, Savill et 
al. 1992; Hoffmann, deCathelineau et al. 2001; Schlegel and Williamson 2001). 
Phosphatidylserine can be easily recognized by the phospholipids-binding protein, 
annexin-V. Therefore, annexin-V binding assay is known for detecting cells in the 
early stage of apoptosis. In contrast, those cells in the late stages of apoptosis or 
already dead can be observed by prodidium iodide (PI) staining (Martin SJ, 
Reutelingsperger CP et al. 1995). PI is a fluorescent vital dye that stains DNA. It does 
not cross the plasma membrane of cells that are viable or in the early stages of 
apoptosis because these cells maintain plasma membrane integrity. However, those 
cells lost plasma membrane integrity in the late stages of apoptosis or already dead 
are permeable to PI (Martin SJ, Reutelingsperger CP et al. 1995). 
 
In the current experiments, in order to follow up the time kinetics of crambene 
stimulation in pancreatic acinar cells, annexin-V/PI binding assay was used. Our 
spectrofluorometry data (Fig. 2.1 Aa) have shown that within 2 hours of crambene 
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treatment, hardly any increase of annexin-V binding was seen in crambene treated 
cells compared with incubation control cells. However, cells with 3~4 hours treatment 
of 2mM crambene showed a significant increase in annexin-V binding, which reached 
the maximum at 3.5 hours. PI staining (Fig. 2.1Ab) showed no significant difference 
between crambene treated and untreated cells during these early time points. However, 
in a later time point such as 6-hour treated group, crambene was shown to increase PI 
staining significantly. Besides the fluorescence measurement, annexin-V binding cells 
were observed by fluorescent microscopy. As shown by Fig. 2.1 B, annexin V-FITC 
binding was observed in 3-hour crambene treated pancreatic acinar cells but not in 
control cells (Fig. 2.1B). Treated cells with bound annexin-V showed punctuated 
green staining in the plasma membrane. These results indicate that treatment of 
pancreatic acinar cells with 2 mM crambene for 3 ~ 4 hours induced the early stages 














Fig 2.1A Detection of annexin V-FITC/ propidium iodide staining in pancreatic 
acinar cells by spectrofluorometry. Samples were quantified by fluorescent plate 
reader with dual filter set for a, FITC and b, Rhodamin after 1 hour, 2 hours, 2.5 
hours, 3 hours, 3.5 hours, 4 hours, 4.5 hours and 6 hours treatment with or without 2 
mM crambene followed by annexin-V/PI binding assay. (n=6, *P < 0.002 when 
compared with corresponding untreated incubation samples). Data were expressed as 
















































































Fig 2.1B Detection of annexin V-FITC/ propidium iodide staining in pancreatic 
acinar cells by fluorescence microscopy. Samples were prepared by 3 hours 
treatment with or without 2 mM crambene followed by annexin-V/PI binding assay. 
Cells were visualized by fluorescence microscopy with 400 × magnification. Cells 
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2.2.2 Crambene stimulates activations of caspases 3, 8, and 9  
In apoptosis, caspases function in both cell disassembly (effectors) and in initiating 
this disassembly in response to proapoptotic signals (initiators) (Thornberry, Rano et 
al. 1997). Caspase 3 has been implicated in the effector phase of apoptosis. Both 
death receptor and mitochondrial pathways converge at the level of caspase 3 
activation to amplify initiation signals into commitment to apoptosis (Thornberry, 
Rano et al. 1997; Nunez, Benedict et al. 1998; Philchenkov 2004; Revankar, Vines et 
al. 2004). Caspase 8 and 9 have been known as the two major upstream activators of 
caspase 3. Caspase 8 and 9 mutant mice exhibit severe defects in developmental 
apoptosis, suggesting that they are critical for activation of apoptosis and caspase 3 
during development (Kuida, Haydar et al. 1998; Bhatia 2004).  In addition, situated at 
pivotal junctions, caspase 8 and 9 initiate death receptor and mitochondrial pathway 
respectively (Nunez, Benedict et al. 1998; Philchenkov 2004); (Thornberry, Rano et 
al. 1997). 
 
In the present study, fluorimetric assay was used to quantify caspase 3, 8 and 9 
activities respectively. The dose 2mM of crambene was determined by preliminary 
caspase 3 asssay. Three doses: 0.2mM, 2mM and 20mM of crambene were examined 
for caspase 3 activation. The activated caspase 3 activity was significantly elevated 
with both 2mM and 20mM of crambene treatment for 3-hour incubation. However, 
no significant difference was observed between these two doses. For this reason, 

































Fig 2.2A Detection of caspase 3 activation in isolated pancreatic acini. Prepared 
acini were incubated with crambene treatment at different doses (0mM, 0.2mM, 
2mM, 20mM) for 3 hours. The caspase 3 activation in corresponding control (0mM 
crambene treated cells) was considered to be 1. (*P < 0.001 when compared with 








Subsequently, we did a time-kinetic analysis of caspase 3, 8 and 9 activation upon 
exposure to 2mM of crambene (Fig 2.2B). Our results showed that within 3 hours of 
treatment, all the three caspases were significantly activated in pancreatic acini. 
However, the kinetics of caspase 8 and 9 always preceded caspase 3 activation, in 
which caspase 8 and 9 activation became significantly at 2.5 hours and 3 hours 


































Fig 2.2B Kinetics of caspase 3, 8, and 9 activation in isolated pancreatic acini. 
Prepared acini were incubated with crambene treatment at different time points. Data 
were expressed as fold increase over corresponding incubation control (e.g. 3hour 
crambene treated cells were compared with 3hour non-treated control cells). (*P < 
0.005 when compared with caspase 3 in non-treated cells; $P< 0.005 when compared 




Moreover, when the corresponding inhibitor for the three caspases (Utaisincharoen, P. 
et al. 1999; Alessandra Marconi, Paola Atzei, et al. 2004; Joanne Mohan, Moira E. 
Bruce, et al. 2005) was used, the activation of these caspases was observed to be 
greatly attenuated. As shown by figure Ca, with the presence of caspase 3 inhibitor 
(Z-DEVD-FMK), the activation of caspase 3 was significantly reduced. Similarly in 
figure 2.3Cb, crambene treatment significantly increased caspase 8 activation by 1.38 
folds compared to untreated acini and the activation was reduced by 28% when 
caspase 8 specific inhibitor Z-IETD-FMK was added. Caspase 9 activation was 
increased by 1.95 folds with crambene treatment, and this activation was significantly 
decreased by 83% when caspase 9 specific inhibitor Z-LEHD-FMK was used (Fig. 
2.2Cc). These results suggested that the activation of caspase 3, 8, and 9 may be 
involved in crambene-induced apoptosis of pancreatic acinar cell.  
 
Since our data have shown the kinetics of caspase 8 and 9 preceded caspase 3 
activation (Fig 2.2B), we further evaluated the effect of caspase 8 and 9 inhibitors on 
activation of caspase 3. As shown in figure 2.2 Da, treatment of Z-LEHD-FMK and 
Z-IETD-FMK blocked caspase 3 activation significantly. These results suggested that 
the activation of caspase 3 may be caspase 8 and 9 dependent.  
 
Moreover, we have evaluated the effect of three caspases’ corresponding inhibitors 
on annexin-V binding. As shown in figure 2.2 Db and Dc, these caspases inhibitors 
can significantly block annexin-V binding as well. These results suggested that the 
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Fig 2.2C Effect of caspases inhibitors on caspases activation in isolated 
pancreatic acini. Prepared acini were incubated with 2mM crambene (CHB) 
treatment with or without Z-DEVD-FMK (a), Z-IETD-FMK (b), Z-LEHD-FMK (c) 
for 3 hours. The caspases activation in corresponding incubation control was 
considered to be 1. (n=6, †P < 0.002 when compared with 3 h untreated samples; *P 
< 0.001 when compared with 3 h crambene treated cells). 
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Fig 2.2D Effect of inhibitors on caspase 3 activation and annexin-V binding in 
isolated pancreatic acini. Prepared acini were incubated with 2mM crambene (CHB) 
treatment with or without Z-IETD-FMK, Z-LEHD-FMK (a,c), Z-DEVD-FMK (b) for 
3 hours. Caspase 3 activity (a) and annexin-V binding (b,c) were determined. The 
caspases activation in corresponding incubation control was considered to be 1. (n=6, 
†P < 0.002 when compared with 3 h untreated samples; *P < 0.001 when compared 
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2.2.3 Crambene stimulates a decrease of mitochondrial membrane potential 
Following crambene treatment the mitochondrial integrity was assessed. As shown in 
Fig. 2.3A (a-f), control pancreatic acinar cells displayed the phenomenon of polarized 
mitochondria, whereas the crambene treated cells had depolarized mitochondria, 
which indicated that in crambene treated pancreatic acinar cells, the mitochondrial 
membrane potential had collapsed.  
 
We also quantified the mitochondrial membrane potential by using a fluorescence 
plate reader (Fig. 2.3B). The relative ratio of red to green fluorescence was 
significantly decreased in crambene treated cells when compared to untreated group. 
Since mitochondrial dysfunction could be mediated by upstream caspases (Scaffidi, 
C., Fulda, S., et al. 1998; Li, H., Zhu, H., et al. 1998). We examined the effect of 
caspase 8 and 9 inhibitors on the change of mitochondrial membrane potential.  Our 
data showed that pretreatment with either Z-LEHD-FMK or Z-IETD-FMK in both 
crambene treated and untreated cells exhibited no alteration on the mitochondrial 
membrane potential. These data suggested that the decrease of mitochondrial 








Fig 2.3 Detection of mitochondrial membrane potential in pancreatic acinar cells. 
Isolated pancreatic acini were incubated with 2 mM crambene for 3 hours followed 
by the treatment of JC-1 reagent for 15 minutes. A, Changes in ∆Ψm were assessed 
by fluorescence microscopy (a-c, control; d-f, crambene; a and d, with green staining 
filter set for fluorescein; b and e , with red staining filter set for Rhodamine; c and f, 
combine images), visualized with 400 × magnification. Polarized mitochondria are 
visualized by punctuated red staining, whereas depolarized mitochondria are 
visualized by their diffuse green staining only. B, Effect of Z-IETD-FMK or Z-
LEHD-FMK on mitochondrial membrane potential in crambene treated acini. 
Samples were quantified by fluorescent plate reader with dual filter set for green 
fluorescence and red fluorescence. Data are expressed as cell retention of JC-1 
(Relative ratio of red to green fluorescence). The level of JC-1 retained by untreated 
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2.3.4 Crambene stimulates a release of cytochrome c from mitochondria 
We analyzed the effect of crambene treatment on the release of cytochrome c from 
mitochondria in pancreatic acinar cells. As shown by Fig. 2.4, the release of 
mitochondrial cytochrome c in treated pancreatic acinar cells was significantly 
increased over 1.33-fold compared to untreated control. These results indicated that 
treatment of acini with 2 mM crambene for 3-hour may stimulate the release of 




Fig 2.4 Detection of the release of cytochrome c release from mitochondria in 
pancreatic acinar cells. Isolated pancreatic acini were incubated with 2 mM 
crambene for 3 hours followed by the isolation of the mitochondria. The released 
cytochrome c from mitochondria was determined by using semi-quantitative 
sandwich ELISA kit. The level of cytochrome c detect from 3 hours incubation 
control cells was considered to be 1. Absorbance was measured at 450 nm with the 




















The extent of pancreatic acinar cell apoptosis has been shown to be inversely related 
to the severity of the acute pancreatitis, suggesting that apoptosis is a teleologically 
beneficial form of cell death in acute pancreatitis. Since prophylactic induction of 
apoptosis has been found to have a protection against acute pancreatitis in animal 
models (Bhatia, Wallig et al. 1998), it is reasonable to speculate that selective 
induction of apoptosis in pancreatic acinar cell may be of value in clinical acute 
pancreatitis, especially in individuals with a high risk of pancreatitis (such as those 
undergoing endoscopic retrograde cholangiopancreatography). However, before one 
could take these studies into the clinic, more basic research is needed into the 
mechanisms of apoptosis in pancreatic acinar cells (Bhatia, 2004b).  
 
In the current study, using the primary isolated pancreatic acinar cells, we 
investigated apoptosis of pancreatic acinar cells induced by crambene through 
studying the key features of apoptosis. Our data showed that treatment of isolated 
pancreatic acini with 2 mM crambene for 3 hours caused externalization of 
phosphatidylserine, increases of caspase 3, 8, and 9 activation, a decrease of 
mitochondrial membrane potential and a release of mitochondrial cytochrome c. 
 
Loss of membrane phospholipid with externalization of PS is an early and widespread 
event during apoptosis (Martin, Siegel et al. 1998). Although the mechanisms 
mediating externalization of PS are still not well defined (van Engeland, Nieland et al. 
1998; Kagan, Fabisiak et al. 2000; Kagan, Borisenko et al. 2003), the exposed PS can 
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be easily detected with annexin V because of its strong affinity for PS (Fadok, Savill 
et al. 1992; Vermes, Haanen et al. 1995). Propidium iodide (PI), the membrane-
impermeable nucleic acid stain, is an index of late-stage cell death. It is excluded by 
early apoptotic cells, but labels all dead cells including necrotic cells and those in the 
final stages of apoptosis (Mayr, Li et al. 2000; Yao and Tabas 2000).  
 
Our results showed that early time points treatment of crambene induced an increase 
of annexin V but not propidium iodide staining in pancreatic acinar cells, which 
indicated that 3~4h treatment of 2 mM crambene induced the early stages of 
apoptosis in pancreatic acinar cells. Moreover, the time-kinetics data of both annexin 
V binding and caspases assay show that the activation of upstream caspases (caspase 
8 and 9) happened earlier than the increase of annexin V binding. Also, all the three 
caspases inhibitors showed partly blocking effects on annexin V binding as well. 
These data suggested that the induction of caspases activation by crambene may 
partially mediate the externalization of PS in pancreatic acinar cells. This observation 
of caspases-mediated PS externalization is also reported by other studies (Debabrata 
Mandal, Prasun K Moitra et al. 2002; Asai K, Buurman WA. et al. 2003; Min DY, 
Lee YA., et al. 2004). 
 
Activation of caspase 3 is another hallmark of apoptotic cell death. It has been shown 
to be an important effector during apoptosis. Both death receptor and mitochondrial 
pathways converge at the level of this effector caspase to amplify initiation signals 
into commitment to apoptosis (Nunez, Benedict et al. 1998; Thornberry and Lazebnik 
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1998; Philchenkov 2004). Caspase 8 and 9, on the other hand, initiate the death 
receptor and mitochondrial pathways respectively, each being situated at pivotal 
junctions in their pathway; hence their activities are regarded as key markers (Nunez, 
Benedict et al. 1998; Thornberry and Lazebnik 1998; Philchenkov 2004).  
 
In the present study, spectrofluorometric assays were used to quantify caspase 3, 8 
and 9 activities respectively. Our data showed that all the three caspases were 
significantly activated in crambene treated pancreatic acinar cells. However, both 
caspase 8 and 9 activated earlier than caspase 3. The activation of caspases was 
blocked when the corresponding inhibitor was added. Moreover, caspase 3 activation 
was blocked significantly by caspase 8 and caspase 9 inhibitors as well. These data 
indicate that both caspase 8 and 9 activation may be involved in activating caspase 3. 
 
Mitochondria play a key role into controlling life and death by releasing cytochrome 
c into the cytosol thereby activating caspases (Reed 1997; Desagher and Martinou 
2000). Permeability changes in the outer mitochondrial membrane, decrease of 
membrane potential, release of cytochrome c and caspase activation are associated 
with the mitochondrial-death pathway (Regula, Ens et al. 2003). The physiological 
importance of cytochrome c release and the subsequent activation of caspase 9 has 
been shown by Apaf-1 or caspase 9 knockout mice, which die perinatally with brain 
outgrowth and reduced apoptosis in the central nervous system (Vaux and Korsmeyer 
1999). Also, cytochrome c deficient mice die earlier during embryonic development 
but this is presumably due to defective mitochondrial oxidative phosphorylation 
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(Vaux and Korsmeyer 1999). We used the fluorescent cationic dye, JC-1, to probe for 
loss of mitochondrial membrane potential. With JC-1 staining, polarized 
mitochondria in normal cells are visualized by punctuated red staining, whereas 
depolarized mitochondria in apoptotic cells are visualized by their diffuse green 
staining (Smiley, Reers et al. 1991).  
 
For the release of cytochrome c from mitochondria in pancreatic acinar cells, we used 
a semi-quantitative sandwich ELISA to evaluate its leakage into the cytosol. After 
isolation of mitochondria from crambene treated cells, the released cytochrome c was 
measured, whereas the retained cytochrome c in the mitochondria was removed 
during washing. Our studies showed that crambene induced a significant 
mitochondrial membrane potential reduction and a significant release of cytochrome c 
from mitochondria as well. Therefore, we suggested that mitochondrial dysfunction 
may be involved in crambene-induced apoptosis of pancreatic acinar cells.  
 
To clarify the possible involvement of death receptor pathway, which is suggested by 
the activation of caspase 8, we analyzed the production of TNF-α and Fas ligand level 
in pancreatic acinar cells after treatment with crambene, but found their levels were 
undetectable in cell supernatant. We also evaluated the effect of caspase 8 inhibitor 
on mitochondrial membrane potential, but no blocking effect was observed. This data 
suggested that the death receptor pathway does not play an important role in 
crambene-induced apoptosis. Even though we did not observe any effect of caspase 9 
inhibitor on mitochondrial membrane depolarization either, this is not surprising, as 
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caspase 9 activation occurs downstream of mitochondrial membrane depolarization. 
However, the current data do not exclude the possibility of the involvement of the 
death receptor pathway. Recent studies have shown that the activation of caspase 8 is 
possible independent of death receptors (Park, Wu et al. 2004). Moreover, the 
activation of caspase 8 can be stimulated indirectly via the mitochondrial pathway 
following activation of caspase 3 (Wieder, Essmann et al. 2001).  
 
Figure 2.5 illustrates the summary of the presented findings put into the context of 
current knowledge. In this study, we demonstrate for the first time, that crambene 
stimulates death signaling mechanisms in pancreatic acinar cells in vitro, including 
PS externalization, caspases activation, mitochondrial depolarization and cytochrome 
c release, leading to apoptosis. This study helps us to confirm that the apoptosis of 
pancreatic acinar cell observed in crambene treated mice in vivo is direct effects of 
crambene. Therefore, in the next study, we investigated the mechanism(s) why 














Fig 2.5. Schematic diagram of the death signaling pathways of crambene-
induced pancreatic acinar cell apoptosis. The signaling pathways proposed by our 
experimental data are summarized. Crambene induces the externalization of PS which 
is partially mediated by caspase 3, 8 and 9 activities. Besides the activation of caspase 
3, 8 and 9, crambene also stimulates the decrease of the mitochondrial membrane 
potential as well as the release of mitochondrial cytochrome c, leading to pancreatic 
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CHAPTER 3: MECHANISMS BY WHICH INDUCTION OF 
APOPTOSIS IN PANCREATIC ACINAR CELLS BY CRAMBENE 
PROTECTS MICE AGAINST ACUTE PANCREATITIS 
3.1 Materials and methods 
3.1.1 Animals   
All experimental procedures were performed in accordance with the Guide for the 
Care and Use of Laboratory Animal (NIH Publication, 1996) and approved by the 
animal ethics committee of National University of Singapore.  
 
Adult male Swiss mice weighting 18-22g were purchased from Laboratory Animal 
Centre, Singapore. Mice were housed in a controlled environment with an ambient 
temperature of 22~26oC and a 12 h light/dark cycle. They were fed with standard 
laboratory chow and given water ad libitum.  
 
3.1.2 In vivo experiments 
3.1.2.1 Crambene administration 
Animals were randomly assigned to administer either vehicle (0.9% v/v NaCl) alone 
or vehicle containing crambene (a kind gift from Dr. Matthew Wallig, more than 99.5 
% pure) at one dose of 70 mg/kg via tail vein injection in a volume of 0.2 ml as 
described previously (Bhatia, Wallig et al. 1998). 0, 12, 18, 24, 36, 48, 72, 96 hours 
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after receiving crambene, samples of pancreas were collected for IL-10 and TGF-β 
assay. Random cross-sections of the head, body, and tail of the pancreas were 
collected for morphological examination and the harvested specimen was fixed in 
10% neutral buffered formalin for hematoxylin/eosin staining. 
 
3.1.2.2 Induction of acute pancreatitis 
Acute pancreatitis was induced by repeated intraperitoneal injections of a 
supramaximally stimulating dose (50 µg/kg) of the cholecystokinin analog, caerulein 
(Bachem, Bubendorf, Switzerland), as described previously (Bhatia, Saluja et al. 
1998; Bhatia, Brady et al. 2000).  
 
For the time course of caerulein administration studies, animals were randomly 
assigned to adminster either saline or crambene as described. After 12 hours, animals 
were given hourly injection of caerulein (50 µg/kg) for 0, 3, 6, 10 hours respectively. 
 
For IL-10 neutralizing studies, animals were divided randomly into five groups, each 
containing 5 mice. All mice were fasted overnight. The five experimental groups 
were established as following:  
1. Control group: mice were administered hourly intraperitoneal injections of 
normal saline (0.9% v/v NaCl) for 10 hours.  
2. Caerulein group: mice were administered hourly intraperitoneal injections of 
saline containing caerulein (50 µg/kg) for 10 hours.  
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3. Crambene + caerulein group: mice were administered saline containing crambene  
at one dose of 70 mg/kg given via a tail vein injection in a volume of 0.2 ml. 
Twelve hours later, mice were administered hourly intraperitoneal injections of 
saline containing caerulein (50 µg/kg) for 10 hours. 
4. Anti-IL-10 + crambene + caerulein group: Mice were administered neutralizing 
monoclonal anti-mouse IL-10 antibody at one dose of 2.5 mg/kg intraperitoneally, 
suitable for in vivo blocking (Abrams JS, Roncarolo MG et al. 1992). Mice were 
then immediately administered saline containing crambene at one dose of 70 
mg/kg given via tail vein injection in a volume of 0.2 ml. Twelve hours later, 
mice were administered hourly intraperitoneal injections of saline containing 
caerulein (50 µg/kg) for 10 hours. 
5. Anti-IL-10 + caerulein group: Mice were administered neutralizing monoclonal 
anti-mouse IL-10 antibody at one dose of 2.5 mg/kg intraperitoneally, suitable for 
in vivo blocking (Abrams, Roncarolo et al. 1992). Twelve hours later, mice were 
administered hourly intraperitoneal injections of saline containing caerulein (50 
µg/kg) for 10 hours.  
 
One hour after the final caerulein injection in all experiments, animals were 
euthanized by an intraperitoneal injection of a lethal dose of pentobarbital. 
Heparinized blood was harvested from the heart then centrifuged.  Plasma was 
removed and stored at –80°C.  Random cross-sections of the head, body, and tail of 
the pancreas were collected for morphological and immunohistochemical evaluation.  
Half of the harvested specimen was fixed in 10% neutral buffered formalin for 
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hematoxylin/eosin staining and TUNEL. The remaining half for 
immunohistochemistry was fixed in 4% buffered paraformaldehyde for 4 hours then 
cryoprotected with 20% sucrose overnight. Additional, samples of pancreas were 
stored at –80°C for subsequent of tissue MPO activity measurement, RT-PCR 
analysis and Western blotting.  Samples of pancreas were also collected for 
determination of water content and for MCP-1, IL-1β, and TNF-α assay. 
 
3.1.2.3 Amylase estimation  
Plasma amylase activity was measured using a kinetic spectrophotometric assay. 
Briefly, plasma samples were incubated with the substrate, 4,6-ethylidene (G7)-p-
nitrophenyl (G1)-1-D-maltoheptoside (1 mM; Sigma, St. Louis, MO) for 4 min at 
37°C and the absorbance was measured twice at 1 min intervals at 405 nm. The 
resulting change in absorbance was used to calculate amylase activity as described 
previously (Marshall, Iodice et al. 1977; Bhatia, Wallig et al. 1998; Bhatia, Brady et 
al. 2002).    
 
3.1.2.4 Pancreatic myeloperoxidase estimation 
Neutrophil sequestration in pancreas was quantified by measuring tissue 
myeloperoxidase (MPO) activity (Bhatia, Brady et al. 2000b). Tissue samples were 
thawed, homogenized in 20 mM sodium phosphate buffer (pH 7.4), centrifuged 
(10,000 × g, 10 min, 4°C) and the resulting pellet was resuspended in 50 mM sodium 
phosphate buffer (pH 6.0) containing 0.5% w/v hexadecyltrimethylammonium 
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bromide (Sigma). The suspension was subjected to four cycles of freezing and 
thawing and further disrupted by sonication (40 seconds). The sample was then 
centrifuged (10,000 × g, 5 min, 4°C) and the supernatant was used for the MPO assay. 
The reaction mixture consisted of the supernatant (50 µl), 1.6 mM 
tetramethylbenzidine (Sigma), 80 mM sodium phosphate buffer (pH 5.4), and 0.3 
mM hydrogen peroxide (reagent volume: 50 µl). This mixture was incubated at room 
temperature for 120 sec, and the reaction was terminated with 50 µl of 2 M H2SO4 
and the absorbance measured at 450 nm. This absorbance was then corrected for the 
dry weight of the tissue sample (Maa, Grady et al. 2000) and results expressed as 
enzyme activity (fold increase over control). 
 
3.1.2.5 Pancreatic water content estimation 
The extent of edema in pancreas was quantitated by measuring tissue water content. 
Pancreatic tissue was weighed before and after desiccation at 60°C for 120 hour. The 
difference between the wet and dry tissue weights was calculated and the data were 
expressed as a ratio of the differnce over wet tissue weight (Frossard, Pastor et al. 
2001).  
 
3.1.2.6 Morphological examination 
Tissue samples were fixed overnight in 10% neutral phosphate-buffered formalin and 
subsequently dehydrated through a graded ethanol series. After impregnation into 
paraffin wax, tissue samples were made into blocks. As previously described (Bhatia, 
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Saluja et al. 1998; Bhatia, Brady et al. 2000b; Bhatia, Slavin et al. 2003; Bhatia, 
Wong et al. 2005), pancreas sections (5 µm) were dewaxed and rehydrated through 
three changes of neoclear and graded alcohol series, rinsed in distill water, stained 
with Gill’s hematoxylin for 4 minutes, differentiated in 0.5% acid alcohol for 5 
seconds, washed in tap water for 5 minutes, and then stained in alcoholic eosin for 30 
seconds, dehydrated and mounted in neomount (Merck). Slides were examined by 
light microscopy using a Carl-Zeiss microscope (objective lens magnification of ×20 
or ×40; eyepiece magnification of ×10).  
 
For quantification of apoptosis by hemtoxylin and eosin staining, apoptotic cells, 
identified using the morphological criteria of Kerr et al. 1995 (Kelly L, Reid L et al. 
1999) were counted in 10 low-power fields (×200), selected at random, in a 
histological slide from each animal at 0, 12, 18, 24, 36, 48, 72, 96 hours after 
receiving crambene provided that mostly acinar tissue filled the field. An estimate of 
the total number of acinar cells per low-power fields in each slide was made for 
calculation of an apoptotic index (apoptotic count as a percentage of total acinar cells 
present). Counts/low-power fields and apoptotic indices were recorded as 
Means+SEM for each group. 
 
Sections of acute pancreatitis examined for tissue injury/necrosis were characterized 
by, (i) edema and destruction of histoarchitecture of whole or parts of the acini for 
pancreas; and (ii) inflammatory cell infiltration into the necrotic areas in pancreatic 
tissue.  Acinar cell injury/necrosis was semi-quantified.  Briefly, 10 randomly chosen 
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microscopic fields (×200) were examined for each tissue sample and the extent of 
acinar-cell injury/necrosis was expressed as the percent of the total acinar tissue that 
was occupied by areas meeting the criteria for injury/necrosis. Those criteria were 
defined as either (i) the presence of acinar-cell ghosts; or (ii) vacuolization and 
swelling of acinar cells and the destruction of the histoarchitecture of whole or parts 
of the acini, both of which had be associated with an inflammatory reaction. 
 
3.1.2.7 IL-10, TGF-β, MCP-1, IL-1β, TNF-α assay 
Pancreatic homogenates were assayed for IL-10, TGF-β, IL-1β, TNF-α and MCP-1 
using a sandwich ELISA according to the manufacturer's instructions (Duoset kit; 
R&D Systems, Minneapolis, MN). Briefly, anti-IL-10, TGF-β, IL-1β, TNF-α, or anti-
MCP-1 primary antibody was aliquoted onto ELISA plates and incubated at room 
temperature overnight. Samples and standards were incubated for 2 h, the plates were 
washed, and a biotinylated anti-IL-10, TGF-β, IL-1β, TNF-α, or anti-MCP-1 antibody 
was added for 2 h. Plates were washed again, and streptavidin bound to horseradish 
peroxidase was added for 20 min. After a further wash, tetramethylbenzidine was 
added for color development, and the reaction was terminated with 2 M H2SO4. 
Absorbance was measured at 450 nm. 
 
3.1.2.8 RT-PCR 
Total RNA was extracted from pancreas with Trizol (R) reagent (Invitrogen, 
Carlsbad, CA, USA) according to the manufacturer’s protocol. The concentration of 
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isolated nuclei acids was determined spectrophotometrically by measuring the 
absorbance at 260 nm and the integrity was verified by ethidium bromide staining of 
18S and 28S rRNA bands on a denaturing agarose gel. All samples were thereafter 
stored at -80 °C until required. One µg RNA was reversely transcribed using 
iScriptTM cDNA Synthesis Kit (Biorad, Hercules, CA, USA) at 25°C for 5 minutes, 
42°C for 30 minutes, followed by 85°C for 5 minutes. Then 2µl of cDNA were used 
as a template for PCR amplification. The primer sequences of 18S, CD36, PSR and 
integrin αvβ3 were as shown in table 3.1. The primers were synthesized by Proligo 
(Singapore). The reaction mixture was first subjected to 95 °C for 3 min for the 
activation of polymerase. This was followed by an optimal cycle of amplifications 
(Table 2.1), consisting of 95°C for 30 s, optimal annealing temperature  for 30 s and 
72 °C for 30 s. PCR amplification was carried out in MyCyclerTM (Bio-rad, Hercules, 
CA, USA). PCR products were analyzed on 1.5 % w/v agarose gels containing 
0.5µg/ml ethidium bromide. Semi-quantitative analysis of band densities was 













Table 2.1: Details of PCR primers 











Sense:5’- CTC ACG ATG AAC CAC AAG AGC -3’
PSR 
Antisense:5’- GGA CCA GCC CTC TTG TGC ATT -3’
56°C 38 246
Sense:5’- TTACCCCGTGGACATCTACTA -3’integrin 




3.1.2.9 Western blotting  
Individual pancreata from mice were homogenized in ice-cold radio-
immunoprecipitation assay (RIPA) lysis buffer (1 ml per 200mg of tissue) using 
polytron homogenizer (heidolph, Germany) after minced with scissors. The RIPA 
lysis buffer contains 1M Tris-HCl (pH 7.5), 150 mM NaCl, 1% NP-40, 0.5% sodium 
deoxycholic acid (NaDoc), 10% sodium dodecyl dulfate (SDS) with a cocktail of 
protease inhibitors (100 µM PMSF, 1 µM leupeptine, 1 µM pepstatine A). After 
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incubation with rotation for 30min at 4oC, the homogenate was centrifuged at high 
speed (13,000 rpm) for 10 minutes at 4°C to remove nuclei and cell debris. Protein 
concentration for each sample was measured with spectrophotometer (TECAN, USA) 
at an absorbance of 595 nm with a BioRad protein assay kit (Bio-Rad Laboratories, 
USA). Samples were aliquot and stored at -80oC until further experiments.  
 
Whole cell lysated (50µg) was diluted with double distilled water and loading buffer 
which contains 80mM Tris (pH 6.8), 2% SDS, 10% Glycerol, 2% Bromophenol Blue 
and 0.76M fresh β-mercaptoethanol (Sigma, USA). The diluted cell lysate was boiled 
at 95°C for 5 min before loading. Proteins were then separated by SDS-
polyacrylamide gel electrophoresis (PAGE) (50 µg/lane) (4% acrylamide stacking gel 
and 10-15% running gel) in electrophoresis buffer (50mM Tris base, 192 mM glycine, 
0.1% SDS), under the constant voltage of 100V in resolving gel and continued 
running at constant 100V till satisfactory protein separation was observed. A dual 
color Precision Plus ProteinTM Standard (Bio-Rad, USA) was running as a protein 
reference. The protein samples in the gel were then electrophoretically transferred to 
nitrocellulose membranes using an electroblotting sandwich apparatus (Bio-Rad) at 
100V for 1h 15min in the transfer buffer (39mM Glycine, 48mM Tris, 0.037% SDS 
and 20% Methanol) at 4oC, according to Bio-Rad protocol. Non-specific binding was 
blocked by 1-hour incubation of the membranes in 5% nonfat dry milk in PBST 
(0.05% Tween-20 in PBS). The blots were then incubated overnight with goat anti-
mouse CD36 polyclonal antibody (R&D system) at 1:2000 dilution in the buffer 
containing 2.5 % nonfat dry milk in PBST at 4oC, washed four times with PBST, and 
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finally incubated for 1 h with a donkey anti-goat horseradish peroxidase-conjugated 
secondary antibody (R&D system) at 1:1000 dilution in the buffer containing 2.5 % 
nonfat dry milk in PBST.  
 
The blots were developed for visualization using enhanced chemiluminescence (ECL) 
detection kit (Pierce, Rockford, IL). Briefly the blots were incubated with a working 
solution of ECL substrate for 30 seconds at room temperature and exposed to X-ray 
film (Amersham-Pharmacia, UK) in dark room for various time durations. Semi-
quantitative analysis of band densities was assessed by scanning densitometry (Gel-
Doc system USA) 
 
3.1.2.10 Terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick-end 
labeling (TUNEL) 
The TUNEL reaction was performed with the ApopTag Plus Fluorescein In situ 
Apoptosis Detection kit (Chemicon International) in accordance with the 
manufacturer's protocol. Briefly, tissue sections were deparaffinized and treated with 
proteinase K (20 µg/ml) for 15 min at room temperature followed by the incubation 
for 15 min with equilibration buffer (Chemicon). Terminal deoxyribonucleotide 
transferase (TdT) enzyme (55 µl) was added to the section and incubated at 37°C for 
1 hour. After three washes in PBS, 65 µl of anti-digoxigenin conjugate was added 
and incubated for 30 minutes at room temperature. After four changes of PBS, the 
slides were mounted and viewed by fluorescence microscopy using band pass filters 
designed to detect FITC.  
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Average number of ongoing apoptosis of pancreatic acinar cell was analyzed in 10 
fields per section under microscope system (Zeiss, Germany) at a magnification of 
×200. The pancreatic acinar cells with positive green fluorescence were defined as 
TUNEL-positive pancreatic acinar cells.  
 
3.1.2.11 Immunohistochemistry and double-immunofluorescence labeling  
Serial sections (7µm) were generated on a cryostat, mounted on gelatin-coated slides. 
Immediately before staining, frozen sections were air dried for 1 hour at room 
temperature (RT), fixed in 100% ice-cold ethanol for 5 minutes, following ethanol 
fixation and 1.5% goat serum blocking, CD36 was visualized after incubation with a 
goat anti-mouse primary antibody (Santa Cruz, CA) at 1:50 dilution in 1.5% goat 
serum and then followed by rabbit anti-goat peroxidase labeled polymer conjugated 
secondary antibody (Chemicon) at 1:500 dilution in 1.5% goat serum. 
Immunostained sections were counterstained with hematoxylin.  
 
For double labeling, tissue sections were incubated with goat anti-mouse CD36 
polyclonal (Santa Cruz, CA) at 1:50 dilution in 1.5% goat serum and rabbit anti-
mouse activated caspase-3 polyclonal (Sigma-Aldrich) at 1:500 dilution in 1.5% goat 
serum, or anti-F4/80 (Santa Cruz, CA) antibodies at 1:50 dilution in 1.5% goat serum. 
Sections were washed and then incubated with appropriate secondary antibodies 
(Alexa Fluor-488 chicken anti rabbit IgG for anti-activated caspase-3 or anti-F4/80 
and Alexa Fluor-568 rabbit anti-goat IgG for anti-CD36, all at 1:200 dilution in 1.5% 
goat serum) for 45 minutes at room temperature. Sections were examined and images 
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acquired on a Carl-Zeiss fluorescent microscope using band pass filters designed to 
detect FITC and rhodamine respectively.  
 
3.1.3 In vitro experiments 
3.1.3.1 Medium 
RPMI 1640 medium (Invitrogen, Carlsbad, CA, USA) was supplemented with 
containing 100 U/ml penicillin, 100 µg/ml streptomycin, and 2 mM glutamine 
(Invitrogen, Carlsbad, CA, USA). Further supplement added to the medium was 10% 
fetal bovine serum (FBS) (HyClone, Lagan, UT, USA), heat inactivated for 30min at 
56oC. The solution is subsequently referred to 10% FBS. 
 
3.1.3.2 Isolation of pancreatic acinar cells and induction of apoptosis  
Pancreata from mice were infused with buffer A (140 mM NaCl, 4.7 mM KCl, 1.13 
mM MgCl2, 1 mM CaCl2, 10 mM glucose, 10 mM Hepes, pH 7.2) containing 200 
IU/ml collagenase using 29G syringe, minced with a sharp tip surgical scissors till a 
fine suspension was achieved, and incubated for 10 minutes at 370C in a shaking 
water bath. The digested tissue was passed through buffer A containing 50 mg/ml 
BSA, and washed twice with buffer A for further experiments. Cell viability was 
determined by trypan blue exclusion. Viability of the cells must be greater than 95% 
for further experiments. 
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The prepared acini were distributed into microfuge tubes (around 1× 105 -1× 106 
pancreatic acinar cells per tube) containing buffer A using a micro pipette. Crambene 
was added into these tubes with the varying working concentration of 2mM. Acini 
were incubated with or without crambene at 370C in a shaker water bath for 3 hours. 
After 3-hour of incubation, cells were washed 3 times in buffer A, and taken up in 
1ml of 10% FBS. Samples of 150µl were taken for analysis of apoptosis.  Apoptosis 
was determined by annexin V-FITC/ staining detection referred to section 2.1.5.  
 
3.1.3.3 Isolation of resident peritoneal macrophages 
Closed peritoneal lavage was performed on anesthetized mice by injection of 10ml 
ice-cold 10% FBS, followed by gravity drainage through a 1.1-mm diameter needle. 
The peritoneal lavage was kept on ice until seeding. Cells were washed once and 
taken up in 4 ml of ice cold 10% FBS. A 20µl sample was taken for counting the total 
number of cells in a hemacytometer. 
 
Peritoneal lavage cells were seeded at 7.5 × 104 in 10% FBS in each 1.8 cm2 well of a 
4-well lab-tekTM glass chamber slide (NUNC, Denmark). Cells were allowed to settle 
and adhere for 1.5 h at 37oC in an incubator, after which non-adherent cells were 
removed by washing with 10% FBS using a standardized protocol of vigorous manual 
washing via a sterilized Pasteur pipette. 0.9ml 10% FBS was refilled per well and 
cells were maintained at 37oC for an additional 1.5 hour. Preparations routinely 
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consisted of >99% mononuclear cells, as verified by Turks staining. Just before the 
interaction stage, the cells were again rinsed with 10% FBS using Pasteur pipette.  
 
3.1.3.4 Interaction between macrophage and apoptotic acinar cells  
0.9ml of freshly washed apoptotic acinar cells was gently added into wells containing 
macrophages, after which the whole chamber slides were placed at 37oC incubator. 
Cells were allowed to interact for 2-hour. Afterwards, non-phagocytosed acinar cells 
were removed by washing with 10% FBS using a standardized protocol of vigorous 
manual washing via a sterilized Pasteur pipette. 
 
3.1.3.5 Double-immunofluorescence labeling  
After taking off the champer structure part with a scalpel, slides were fixed with 3.7% 
formaldehyde for 10 min followed by extensive washing with PBS. Slides were then 
blocked with 2% FBS for 45 minutes.  
 
Areas for macrophages seeding alone were incubated with rabbit anti-mouse F4/80 
antibodies (Santa Cruz, CA) at 1:100 dilution in 2% FBS and goat anti-mouse CD36 
polyclonal (Santa Cruz, CA) at 1:200 dilution in 2% FBS. Slides were washed and 
then incubated with appropriate secondary antibodies (Alexa Fluor-488 chicken anti 
rabbit IgG for anti-F4/80 and Alexa Fluor-568 rabbit anti-goat IgG for anti-CD36, all 
at 1:200 dilution in 2% FBS) for 30 minutes at room temperature. Slides were 
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allowed to dry under air for at least 15-min and were mounted with fluorescent 
mounting medium (DAKO). Images acquired on a Carl-Zeiss fluorescent microscope 
using band pass filters designed to detect FITC and rhodamine respectively.  
 
Areas for macrophages seeding with pancreatic acinar cells were incubated with goat 
anti-mouse CD36 polyclonal (Santa Cruz, CA) at 1:200 dilution in 2% FBS followed 
by incubation with Alexa Fluor-568 rabbit anti-goat IgG for anti-CD36 at 1:200 
dilution in 2% FBS for 30 minutes at room temperature. Following washing, slides 
were then incubated with 10 µg/ml Hoechst dye for 10 min according to current 
protocols in cell biology. After washing, slides were allowed to dry under air for at 
least 15-min and were mounted with fluorescent mounting medium (DAKO). Images 
acquired on a Carl-Zeiss fluorescent microscope using band pass filters designed to 
detect DAPI and rhodamine respectively.  
 
3.1.4 Analysis of data 
Statistical analysis of the data was accomplished using one way analysis of variance 
(ANOVA). The data reported in this study represent mean ± SEM from multiple 
determinations in three or more different experiments. Differences in the observed 






3.2.1 In situ detection of apoptosis by hematoxylin and eosin staining. 
Mice were given a single intravenous injection of crambene (70 mg/kg) and sacrificed 
at 0 hrs, 12 hrs, 18 hrs, 24 hrs, 36 hrs, 48 hrs, 72 hrs, or 96 hrs after crambene 
administration. Histological sections of pancreas were performed hematoxylin and 
eosin staining and then visualized by light microscopy with 40×magnification. 
Apoptotic cells show that condensed nuclei with crescent shape (indicated by black 
arrows). Fig 3.1 shows crambene induces apoptosis of pancreatic acinar cell in vivo. 
The number of apoptotic acinar cells peaked at 12 hours after crambene treatment and 
started to decrease at 18 hours after crambene administration. 72 hours later, 
apoptosis was not detectable. This result suggested the clearance of apoptotic cells 
may begin dominating at 18 hours after crambene administration, which is consistent 













































Fig 3.1 Pancreatic morphology. Mice were given a single intravenous injection of 
CHB (70mg/kg) and sacrificed at 12h, 18h, 36h, 48h, 72h, and 96h after CHB 
administration. Histological sections of pancreas were performed hematoxylin and 
eosin staining and then visualized by light microscopy with 400×magnification. 
Apoptotic cells show crescent nuclei (indicated by black arrows in zoom in figures). 










3.2.2 Effect of crambene treatment on the severity of caerulein-induced acute 
pancreatitis as a function of time 
Twelve hours after crambene or vehicle treatment, groups of mice were given hourly 
injections of caerulein for 0, 3, 6, or 10 hours respectively. The severity of pancreatic 
injury was signified by the significantly increased plasma amylase, pancreatic edema 
and MPO compared to control mice of 0 hour-treatment. As shown in figure 3.2, 
caerulein hyperstimulation results in a time-related increase in severity of acute 
pancreatitis. Prophylactic administration of crambene attenuates the severity of acute 
pancreatitis prominently in mice given ten hourly caerulein injections. However, the 
protective effect of crambene in terms of hyperamylasemia attenuation starts in mice 
receiving six hourly caerulein injections, namely, 18 hours after one dose of 
crambene prophylactic treatment. Since the clearance of apoptotic cells dominates 
from 18 hours after crambene administration as suggested by figure 3.1, the current 
data indicate that the hyperamylasemia attenuation effect of crambene may be 
temporally coincident with clearance of apoptotic cells. In other words, phagocytosis 
















































































Fig 3.2 Time course study of crambene treatment on the severity of caerulein-
induced acute pancreatitis. Mice (n = 12 in each group) were given hourly injection 
of caerulein (Cae) for 0, 3, 6, 10 hours respectively with or without 12-hour crambene 
(CHB) prophylactic treatment. Mice were sacrificed one hour after the last caerulein 
injection.  Plasma amylase activity (A), pancreatic water content (B), pancreatic MPO 
activity (C), were determined as described in MATERIALS AND METHODS. 
Results shown are the means ± SE of three independent experiments, *P< 0.01 when 





3.2.3 RT-PCR analysis of phagocytic receptors in acute pancreatitis 
To display the phagocytosis in acute pancreatitis in vivo, we investigated pancreatic 
expression of key phagocytic receptors found on the memberane of macrophages, 
such as PSR, integrin αvβ3, and CD36, under conditions that result in acute 
pancreatitis. The mRNA levels of these molecules were all detectable in normal 
pancreas. However, both PSR and integrin αvβ3 mRNA in all caerulein treated groups 
were shown similar levels to control groups, without significant changes in mice 
pretreated with crambene (Fig.3.3A). On the contrary, CD36 mRNA showed a time 
dependent elevation in mice with crambene pretreatment compared with control 
untreated mice. Moreover, pretreatment with crambene significantly upregulated 
mRNA levels of CD36 compared with mice receiving six and ten hourly caerulein 
injections alone. In other words, the increase of pancreatic CD36 mRNA may be 
temporally coincident with phagocytosis. Therefore, CD36 is likely to be the primary 






















Fig 3.3A RT-PCR analysis of PSR and integrin β3 
Mice (n = 12 in each group) were given 10 hourly injections of caerulein (Cae) with 
or without 12-hour crambene (CHB) prophylactic treatment. One hour after the last 
caerulein injection, mice were sacrificed and mRNA levels of PSR and integrin β3 
were examined as described in MATERIALS AND METHODS. Aa. Gel 
photographs showing the RT-PCR analysis of PSR and integrin β3 mRNA in 10-hour 
caerulein (Cae) with or without 12-hour crambene (CHB) prophylactic treatment. 
Mouse 18S rRNA was amplified as a loading control. Ab.Quantitation of RT-PCR 
analysis showing the RT-PCR analysis of PSR and integrin β3. 
 
Aa. 


























































CD36 mRNA level in pancreas
 
Fig 3.3B RT-PCR analysis of CD36 
Mice (n = 12 in each group) were given hourly injection of caerulein (Cae) for 0, 3, 6, 
10 hours respectively with or without 12-hour crambene (CHB) prophylactic 
treatment. One hour after the last caerulein injection, mice were sacrificed and mRNA 
level of CD36 were examined as described in MATERIALS AND METHODS. Ba. 
Gel photographs showing the RT-PCR analysis of CD36. Mouse 18S rRNA was 
amplified as a loading control. Bb. Quantitation of RT-PCR analysis. *P< 0.01 when 







    Bb. 
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3.2.4 Clearance of apoptotic acinar cells via CD36 positive macrophages 
To identify the cells that express CD36, double immunofluorescence labeling was 
performed in pancreatic sections from mice pretreated with crambene followed by 
10-hourly injection of caerulein, using antibodies against CD36 and F4/80. F4/80 is a 
well known macrophage-specific marker present on the surface of most macrophages 
(Austyn and Gordon 1981; Khazen, M'Bika J et al. 2005). As indicated in upper 
panel of Fig 3.4, CD36 stained cells are co-located with F4/80 marked cells. However, 
not all F4/80 positive cells in acute pancreatic sections labeled with CD36 (Fig 3.4, 
lower panel).  This data suggest that macrophages in pancreas are the major cells 

















Fig 3.4 Double immunofluorescence labeling of CD36 and F4/80 in pancreatic 
section. Shown are two different pancreatic cryosections from 10-hourly caerulein 
induced pancreatitis with pretreatment of crambene, examined for the expression of 
CD36 (red) and F4/80 (green) by immunofluorescent microscopy. The merged 
images (center) indicate whether these two proteins are colocalized in the same cell. 





F4/80 Merged CD36 
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To investigate the locational relationship between phagocytic cells and apoptotic cells, 
we used TUNEL staining and double immunofluorescent staining. As shown in 
figure 3.5, prophylactic administration of crambene results in a significant increase of 




Fig 3.5 Detection of apoptosis after 12-hour crambene administration. Pancreatic 
sections were analysed using terminal deoxynucleotidyltransferase-mediated dUTP-
biotin nick-end labelling (TUNEL). Mice were injected with 10-hourly caerulein (Cae) 
and in the presence or absence of crambene (CHB) treatment, which was 
administered 12 hour before the first caerulein injection (original magnification ×200). 
White arrows indicate the positive stained cells. Number of apoptotic cells in ten 








Moreover, double immunofluorescence labeling was performed in pancreatic sections 
of mice pretreated with crambene followed by 10 hourly injections of caerulein, 
using antibodies against CD36 and activated caspase-3, a known hallmark of 
apoptosis. As shown in lower panel of figure 3.6 (merged), activated caspase-3 
labeled cells (left) were observed close to CD36 (right) stained cells. This indicates 
macrophages may act as the phagocytic cells and carry out their phagocytosis through 



















Fig 3.6 Double immunofluorescence labeling of CD36 and activated caspase-3 in 
pancreatic sections. Pancreatic cryosections from saline treatment only (upper panel) 
or 10-hourly caerulein induced pancreatitis with pretreatment of crambene (lower 
panel), examined for the expression of CD36 (red) and activated caspase-3 (green) by 
immunofluorescent microscopy. The merged images (center) indicate that CD36 




















This conclusion was supported by our in vitro findings. In Chapter 2, we have shown 
that treatment of 2mM crambene in isolated pancreatic acinar cells for 3 hours 
induces the apoptosis of pancreatic acinar cells. Therefore, in the current study, we 
co-cultured the apoptotic acinar cells which were induced by the treatment of 
crambene as described above, with isolated primary peritoneal macrophage from the 
same mouse in a chamber slide for 2 hours. After rigorous washing and 
immunofluorescent staining, an increased CD36 immunoactivity was found on the 
membrane of macrophages, which ingested the apoptotic body of pancreatic acinar 
cell (Fig 3.7 F). Therefore, CD36 positive macrophage seems play an important role 



















Fig 3.7 CD36 detection on surface of macrophages, which phagocytosed 
apoptotic acinar cells.  
A-C: mouse resident peritoneal cells were isolated and maintained in RPMI 1640 
medium, after vigorous manual washing, the remaining cells were stained as follows. 
A. Turk's stain (nuclear stain) shows nuclear morphology of macrophage (original 
magnification 400×); B and C, double immunofluorescence labeling of F4/80 (B, 
green) and CD36 (C, red) on macrophages. The images indicate the isolated resident 
peritoneal cells well F4/80 positive but CD36 negative (original magnification 1000×).  
D-F: mouse resident peritoneal cells were isolated and cocultured with pancreatic 
acinar cell at early stage of apoptosis induced by crambene for 2 hours, after vigorous 
manual washing, the remaining cells were stained as follows. D. Turk’s stain showed 
macrophages ingested apoptotic bodies. Black arrows indicate cases of phagocytosis 
(original magnification 400×); E and F, double fluorescence labeling of Hoechst 
33342 stain (bis-benzimide) (E, blue) and CD36 (F, red). Hoechst 33342 stain shows 
that what macrophages ingested are apoptotic cell bodies as evidenced by condensed 
nuclei, indicated by a white arrow. CD36 staining shows that macrophages which 
ingested apoptotic acinar cells are indeed CD36 positive, indicated by a white arrow 









3.2.5 Effect of crambene treatment on levels of pro-inflammatory mediators in 
caerulein-induced acute pancreatitis as a function of time 
In order to determine the possible anti-inflammatory responses of crambene-mediated 
phagocytosis during acute pancreatitis, we investigated the effect of crambene 
treatment on pancreatic levels of pro-inflammatory mediators such as MCP-1, IL-1β 
and TNF-α in acute pancreatitis. As shown in Fig 3.8, caerulein hyperstimulation 
causes a time dependent increase of pancreatic MCP-1 and IL-1β levels whereas the 
expression of TNF-α is significantly upregulated within three hours after acute 
pancreatitis induced by caerulein. Prophylactic administration of crambene 
significant attenuates, in a time dependent manner, the elevation of MCP-1 protein 
expression levels in the pancreas (Fig 3.8A).  Pancreatic TNF-α and IL-1β levels 
were significantly attenuated by crambene in mice receiving three and six hourly 
caerulein injections respectively (Fig 3.8 B and C). Nevertheless, this generalized 
attenuation of pro-inflammatory mediators was not temporally coincident with 















































































Fig 3.8 Time course study of crambene treatment on levels of pro-inflammatory 
mediators in the caerulein-induced acute pancreatitis. Mice (n = 12 in each group) 
were given hourly injection of caerulein for 0, 3, 6, 10 hours respectively with or 
without 12-hour crambene (CHB) prophylactic treatment. One hour after the last 
caerulein (Cae) injection, mice were sacrificed and pancreatic level of MCP-1 (A), 
TNF-α (B), IL-1β (C), were determined as described in MATERIALS AND 
METHODS. Results shown are the means ± SE of three independent experiments. *P 
< 0.01 when compared between caerulein treated group with or without CHB 
prophylactic treatment. 





3.2.6 Effect of crambene treatment on levels of anti-inflammatory mediators in 
the pancreas 
Besides pro-inflammatory cytokines, pancreatic anti-inflammatory mediators were 
studied from 12 hours to 96 hours after intravenous administration of crambene at a 
single dose of 70mg/kg. Fig 3.9 shows that compared to untreated control groups, 
levels of pancreatic IL-10 (Fig 3.9A) were significantly increased for 30 hours (i.e., 
from 18 to 48 hours) after crambene administration, whereas TGF-β (Fig 3.9B) was 
only increased significantly at 12 hours compared to untreated control groups. This 
suggested crambene-mediated phagocytosis may stimulate an anti-inflammatory 




Fig3. 9 Effect of crambene treatment on anti-inflammatory mediators levels in 
pancreas. Mice (n = 10 in each group) were given crambene via tail vein injection 
and  0, 12, 18, 24, 36, 48, 72, 96 hours after receiving crambene, samples of pancreas 
were collected for IL-10 and TGF-β assay. A. levels of IL-10 in pancreas; B. levels of 
TGF-β in pancreas. **P < 0.01 when crambene-treated animals were compared with 
placebo-treated animals. *P < 0.05 when crambene-treated animals were compared 














3.2.7 Effect of co-cultures of early apoptotic acinar cells with peritoneal 
macrophages on IL-10 production 
To clarify whether the production of IL-10 results from phagocytosis of apoptotic 
acinar cells, levels of IL-10 was determined in supernatant from cocultures of 
apoptotic acinar cells and resident peritoneal macrophages. Fig 3.10 shows a 
significant increase of IL-10 levels in supernatants from cocultures of both 
macrophage and apoptotic acinar cells, compared to IL-10 levels in those from 
macrophage culture alone. We also analyzed the production of IL-10 level in 
pancreatic acinar cells after treatment with crambene for 3 hours to exclude the 
possibility that apoptotic cell may itself produce IL-10. However, the levels of IL-10 
are too low to be detected in this case. Therefore, the significant increase of IL-10 
levels in supernatant from cocultures is likely due to the interaction between 
macrophages and apoptotic acinar cells. This indicates that phagocytosis of apoptotic 
































Fig 3.10. Effect of cocultures of early apoptotic acinar cells with peritoneal 
macrophages on IL-10 production. Mouse primary peritoneal macrophages (Mφ) 
were cultured with or without the apoptotic pancreatic acinar cells (Apo) in a 
chamber slide for 2 hours. Supernatants of cultures were collected for IL-10 assay. 
(*P < 0.01 when IL-10 levels in supernatants which harvested from cocultures 












3.2.8 Effect of pretreatment with neutralizing anti-IL-10 antibody and crambene 
on the severity of caerulein-induced acute pancreatitis 
In order to further establish the role of phagocytosis-stimulated the production of IL-
10 during crambene-mediated protection in acute pancreatitis, we used a neutralizing 
antibody against IL-10 to investigate if the protection of crambene would be removed. 
The severity of pancreatic injury in caerulein-induced acute pancreatitis is 
characterized by significantly increased plasma amylase, pancreatic edema, MPO, 
and MCP-1 compared to non-treated controls (Fig 3.11). The morphological changes 
in acute pancreatitis, which consist principally of edema, neutrophil infiltration, and 
acinar cell injury/necrosis in this model, were clearly observed in pancreatic sections 
of mice treated with caerulein alone group (Fig 3.12). Prophylactic administration of 
crambene significantly attenuated the severity of acute pancreatitis as expected (Fig 
3.11 and 3.12).  
 
However, prophylactic administration of anti-IL-10 antibody together with crambene 
results in a significant increase of the magnitude of hyperamylasemia, pancreatic 
edema, pancreatic MPO and pancreatic MCP-1 levels compared to the non-treated 
controls (Fig 3.11). Moreover, the histomorphological changes of this group (anti-IL-
10 + crambene + caerulein, Fig 3.12 B) were more severe compared to the crambene 
+ caerulein group (Fig 3.12 C) in terms of acinar cell injury/necrosis and pancreatic 
edema. These results demonstrated that administration of anti-IL-10 antibody 
together with crambene 12 hours before caerulein injection significantly reversed all 
the crambene-mediated protection against acute pancreatitis. 
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To exclude the possibility that neutralizing IL-10 may affect IL-10 produced by 
factors other than crambene in caerulein-induced acute pancreatitis, we designed one 
group with pretreatment of anti-IL-10 antibody alone 12 hours before caerulein 
injection. As shown in Fig 3.11 and 3.12, prophylactic administration of anti-IL-10 
antibody alone has no affect on the severity of caerulein-induced pancreatic injury. 
These data suggested that in our experiment, the neuralizing IL-10 may not affect IL-



































































Fig 3.11 Effects of neutralizing anti-IL-10 antibody and crambene pretreatment 
on the severity of caerulein-induced acute pancreatitis.  
Mice (n = 5 in each group) were given 10 hourly injections of caerulein (Cae; 50 
µg/kg i.p.). Anti-IL-10 antibody (Ab; 50 µg per mouse i.p.) was administered to mice 
either with or without crambene 12 hours before the first caerulein injection. One 
hour after the last caerulein injection, mice were killed and plasma amylase activity 
(A), pancreatic water content (B), pancreatic MPO activity (C), pancreatic acinar cell 
injury/necrosis (D), and pancreatic MCP-1 levels (E) were determined as described in 
MATERIALS AND METHODS. Results shown are the means ± SE of three 
independent experiments. *P < 0.01 when treated animals were compared between 















Fig 3.12. Morphological changes in mouse pancreas of acute pancreatitis. 
A: control; no pancreatitis. B: caerulein-induced acute pancreatitis with pretreatment 
of anti-IL-10 and crambene. C: caerulein-induced acute pancreatitis with pretreatment 
of crambene. D: caerulein-induced acute pancreatitis. E: caerulein-induced acute 
pancreatitis with pretreatment of anti-IL-10. Changes in acute pancreatitis include 
various extents of pancreatic edema, destruction of histoarchitecture of the acini, and 
infiltration of inflammatory cells into the necrotic area and acinar cell injury/necrosis. 
A yellow asterisk indicates acinar cell injury/necrosis. 
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3.3.9 mRNA and protein expression of CD36 in caerulein-induced acute 
pancreatitis with pretreatment of neutralizing anti-IL-10 antibody and 
crambene  
To investigate whether neutralizing IL-10 would affect crambene-mediated 
phagocytosis in acute pancreatitis, we did RT-PCR, western blotting and 
immunohistochemistry to examine both mRNA and protein expression of CD36 in 
acute pancreatitis. Fig 3.13A shows a representative RT-PCR analysis of pancreatic 
CD36 mRNA levels in acute pancreatitis. Consistently, prophylactic pretreatment 
with crambene results in a significant increase of CD36 mRNA level compared to 
caerulein hyperstimulation alone group. Similar increase of CD36 mRNA level was 
also shown in pretreatment of anti-IL-10 together with crambene. This is despite the 
fact that pretreatment of anti-IL-10 alone dose not significantly alter the levels of 
CD36 mRNA in caerulein alone group (Fig 3.13A). Therefore, these data suggested 
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Fig 3.13A. Examination of expression of CD36 in mouse pancreas of acute 
pancreatitis with/without prophylactic treatment of anti-IL-10 
antibody/crambene. Quantitation and representative gel photographs of RT-
PCR analysis. Mice (n = 5 in each group) were given 10 hourly injections of 
caerulein (Cae; 50 µg/kg i.p.). Anti-IL-10 antibody (Ab; 50 µg per mouse i.p.) was 
administered to mice either with or without crambene 12 hours before the first 
caerulein injection. One hour after the last caerulein injection, mice were sacrificed 
by an intraperitoneal injection of a lethal dose of pentabarbitone, mRNA level of 
CD36 expression was examined as described in MATERIALS AND METHODS. 
18S rRNA was used as a loading control. *P < 0.01 when treated animals were 
compared between caerulein treated group with or without crambene prophylactic 
treatment.  
           
           
           







Fig 3.13B shows a representative western blot analysis of pancreatic CD36 in acute 
pancreatitis. After adjusting for protein loading as determined by HPRT optical 
density, the abundance of CD36 is significantly upregulated in both groups of mice 
given the prophylactic treatment of either crambene or both anti-IL-10 and crambene, 
compared to the CD36 protein expression levels in control mice treated with 
intraperitoneal normal saline. Again, no significant changes were observed in 
pancreata of mice that received either caerulein treatment alone or anti-IL-10 
antibody treatment prophylactically 12 hours before injection of caerulein. These 
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Fig 3.13B. Examination of expression of CD36 in mouse pancreas of acute 
pancreatitis with/without prophylactic treatment of anti-IL-10 
antibody/crambene. Quantitation and representative photograph of western blot 
analysis. Mice (n = 5 in each group) were given 10 hourly injections of caerulein 
(Cae; 50 µg/kg i.p.). Anti-IL-10 antibody (Ab; 50 µg per mouse i.p.) was 
administered to mice either with or without crambene 12 hours before the first 
caerulein injection. One hour after the last caerulein injection, mice were sacrificed 
by an intraperitoneal injection of a lethal dose of pentabarbitone, protein level of 
CD36 expression was examined as described in MATERIALS AND METHODS. 
HPRT protein was used as a loading control. *P < 0.01 when treated animals were 







As shown in Fig 3.14, CD36 immuno-expression is very low in the normal pancreas. 
However, the immunoactivity of CD36 is similarly upregulated in pancreatic sections 
of mice given crambene or given crambene together with anti-IL-10 antibody. 
Pancreatic sections from mice that administered either caerulein treatment alone or 
anti-IL-10 + caerulein had similar low expression of CD36. The 
immunohistochemical results are consistent with the data of both RT-PCR and 
western blotting analysis. Since our pervious data have shown that crambene-
mediated phagocytosis is primarily through CD36 positive macrophages in acute 
pancreatitis (Fig 3.4, 3.6 and 3.7), these unchaged CD36 levels in neutralizing IL-10 
groups suggest that neutralizing IL-10 does not affect crambene-mediated 


























































Fig 3.14. Immunohistochemical examination of CD36 expression in mouse 
pancreas. Mice were given 10 hourly injections of caerulein (Cae). Anti-IL-10 
antibody (Anti-IL-10) was administered to mice either with or without crambene 
(CHB) 12 hours before the first caerulein injection. One hour after the last caerulein 
injection, mice were sacrificed and pancreatic cryosections were prepared as 
described in MATERIALS AND METHODS. A-E, magnificent x 400; F-J are higher 
magnification (x1000). Cells positive for CD36 are full of ingested brown pigment in 









Apoptosis is a teleologically beneficial form of cell death in acute pancreatitis. 
However, the exact mechanism by which the induction of apoptosis protecting 
against progression toward acute pancreatitis is still not clear. This study shows that 
crambene induces phagocytosis of apoptotic acinar cells by CD36 positive 
macrophages during acute pancreatitis. The anti-inflammatory effect of the 
phagocytosis is mediated by the production of pancreatic anti-inflammatory 
mediators such as IL-10. Besides the anti-inflammatory response of phagocytosis, 
suppressing levels of pancreatic pro-inflammatory mediators also contributes to 
crambene mediated-protection against mouse acute pancreatitis.  
 
It is well known that the final phase of apoptosis in vivo is swift with rapid 
phagocytosis of intact 'unwanted' cells by resident tissue macrophages (Savill, 
Dransfield et al. 2002; de Almeida and Linden 2005). Our data also suggest that in 
pancreas, macrophages are the major means of clearance of apoptotic acinar cells. 
However, the large complexity of pattern of recognition receptors depends on the 
means of induction of cell death, cell type including both apoptotic cells and 
phagocytes, as well as the surrounding microenvironment (Savill, Dransfield et al. 
2002; de Almeida and Linden 2005) For instance, PSR has been recently reported to 
be expressed on pancreatic cells other than macrophages in human chronic 
pancreatitis, in particular regions with high apoptotic activity (Koninger, Balaz et al. 
2005). Integrin αvβ3 is a molecule that was observed to be involved in phagocytotic 
clearance during retinal detachment in the mouse (Hisatomi, Sakamoto et al. 2003).  
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Expression of CD36 has been found to be expressed in rat acute pancreatitis (Shimizu, 
Kobayashi et al. 2005). In the current study, the increase of CD36 expression has 
always been observed in mice with crambene prophylactic administration compared 
with mice without that treatment. Our in vitro data also shows that it is CD36 positive 
macrophage that takes up the apoptotic acinar cells. Therefore, it is much likely that 
CD36 positive macrophages are mainly involved in crambene-mediated phagocytotic 
clearance in mouse acute pancreatitis in vivo. 
 
A convincing body of evidence shows that phagocytes not only phagocytose 
apoptotic cells, they also respond to apoptotic cell death by suppressing inflammation 
(Bzowska, Guzik et al. 2002). It has been suggested that the recognition of PS 
positive apoptotic cells by macrophages through a PSR-mediated mechanism may 
play an important signaling role in the release of TGF-β1 during the clearance of 
apoptotic cells (Fadok, Savill et al. 1992; Monks, Rosner et al. 2005). PS-PSR 
bridging protein TSP1, and other PS non-specific binding receptors such as CD36 
and vitronectin receptor also have been reported to be able to suppress inflammatory 
responses of monocyte/macrophage by stimulating TGF-β1 release (Voll, Herrmann 
et al. 1997; Freire-de-Lima, Nascimento et al. 2000). Annexin I, a newly defined 
endogenous ligand for tethering and internalization of apoptotic cells, can stimulate 
IL-10 production and inhibit nitric oxide synthesis (Ferlazzo, D'Agostino et al. 2003). 
Our in vivo data of present study demonstrates that inducing production of IL-10 by 
crambene is temporally coincident with clearance of apoptotic cells and our in vitro 
data also support that phagocytosis of apoptotic acinar cells indeed stimulates the 
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production of IL-10 by macrophages. Therefore phagocytosis of apoptotic acinar 
cells seems to play a major role in production of IL-10 and may correlate with 
crambene-mediated protection. Furthermore, when IL-10 production by crambene 
was blocked, the protective effects of crambene against acute pancreatitis were 
significantly impaired. This is despit the fact that the neutralizing IL-10 does not 
affect the expression of CD36. These results signify that it is IL-10 production, but 
not increase of CD36, that play the important role in crambene-madiated protection 
during acute pancreatitis.  
 
Not only can phagocytosis suppress inflammatory response, but also the number of 
cells undergoing apoptosis (Majai, Petrovski et al. 2006). Unlike necrotic cells, 
apoptotic cells maintain membrane integrity before phagocytosis. Therefore, leakage 
of intracellular components (e.g. pro-inflammatory and immunogenic materials) 
should be prevented to actively avoid inflammatory response (Piredda, Amendola et 
al. 1997; Majai, Petrovski et al. 2006). Moreover, apoptotic cells may themselves 
produce anti-inflammatory factors such as IL-10 and TGF-β1. The persistent 
appearance of apoptotic cells in inflamed tissues could provide a prolonged anti-
inflammatory stimulus and help to inhibit long term tissue damage (Majai, Petrovski 
et al. 2006). Our present study shows that production of TGF-β1 by crambene 
happens before phagocytosis, but the increase levels of TGF-β1 is temporally 
coincident with induction of maximal apoptosis by crambene as suggested by our 
previous study (Bhatia, Wallig et al. 1998). This indicates that the release of TGF-β1 
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may be due to the apoptosis of pancreatic acinar cell per se but not clearance of 
apoptotic cells. 
 
Besides the release of anti-inflammatory cytokines, we investigated the effect of 
crambene treatment on pancreatic levels of pro-inflammatory mediators such as 
MCP-1, IL-1β and TNF-α in acute pancreatitis. MCP-1 (monocyte chemoattractant 
protein 1, a CC chemokine) has been regarded as the major chemokine in pancreatitis. 
Significantly elevated local and systemic concentrations of MCP-1 have been 
demonstrated in both experimental and clinical acute pancreatitis (Bhatia, Brady et al. 
2002; Rau, Baumgart et al. 2003; Bhatia, Ramnath et al. 2005; Marra 2005). IL-1β 
and TNF-α are potent proinflammatory cytokines that are predominantly derived 
from activated macrophages. These two cytokines are involved in the inflammatory 
cascade subsequent to acinar cell damage and their levels are elevated upon the onset 
and during the progress of acute pancreatitis (Bhatia, Brady et al. 2000; Bhatia, Brady 
et al. 2000; Bhatia, Neoptolemos et al. 2001). In the present study, prophylactic 
treatment of crambene showed a generalized attenuation of these pro-inflammatory 
mediators. Hence, reduced production of pro-inflammatory mediators such as TNF-α, 
IL-1β and MCP-1 levels is probably a separate effect of crambene but may not 
correlate to phagocytosis-mediated protection against acute pancreatitis.  
 
Caerulein-induced acute pancreatitis in mice results in low levels of apoptosis but 
high levels of necrosis, whereas caerulein-induced acute pancreatitis in rat results in 
high levels of apoptosis but low levels of necrosis (Rau B, Baumgart K., et al. 2003) 
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Further exploration of the role of apoptotic cell clearance in acute pancreatitis in rat, 
which has a high level of apoptosis to begin with, may be required for future studies. 
 
Our previous work has demonstrated that crambene dose not alter the interaction of 
caerulein to its receptor on pancreatic acinar cells (Bhatia, Wallig et al. 1998; 
Frossard, Rubbia-Brandt et al. 2003). Therefore, it is unlikely that the apoptotic 
response and the prophylactic effect of crambene are specific to caerulein model. 
However, there is potential for further studies in other experimental models of acute 
pancreatitis such as L-arginine-fed animals or CDE-diet and it would be interesting to 
see if the apoptotic response and the prophylactic effect of crambene in those models 
are similar to those in the caerulein model.  
 
Although clearance of apoptotic cells regulating immune responses have been shown 
in many experimental system, to the best of our knowledge, this is the first study to 
report the clearance of apoptotic cells with its anti-inflammatory properties which 
regulates immune responses in acute pancreatitis.  However, the exact mechanisms by 
which crambene suppresses the production of pro-inflammatory mediators remain to 
be understood. Moreover, the signaling pathways in regulating immune responses by 




CHAPTER 4: SUMMARY OF CONTRIBUTIONS 
Since late 90s, apoptosis has been established as a teleologically beneficial form of 
cell death in acute pancreatitis. Till now, little is known about the mechanisms of 
apoptosis in pancreatic acinar cell and mechanisms by which introduction of 
apoptosis protects against acute pancreatitis.  
 
Previous studies have shown that stimulation of isolated rat pancreatic acini with 
cholecystokinin, which serves as a model for human acute pancreatitis in vitro, 
induces death-signaling pathways in rat pancreatic acinar cells, including caspase 
activation, cytochrome c release, and mitochondrial depolarization. The 
mitochondrial dysfunction is mediated by upstream caspase(s) (Gukovskaya, 
Gukovsky et al. 2002; Gukovsky, Reyes et al. 2003). However, since CCK also 
induce experimental acute pancreatitis, it would be difficult to determine the exact 
role of apoptosis in acute pancreatitis when CCK is used to induce both apoptosis of 
pancreatic acinar cell and acute pancreatitis at the same time.  
 
Menodione, another apoptosis inducer, has been shown to evoke repetitive cytosolic 
Ca2+ spikes, partial mitochondrial depolarization, cytochrome c release and apoptosis 
of pancreatic acinar cells in vitro (Sherwood, Prior et al. 2007). But there are no 
reports on its in vivo effect in acinar cell death as well as in acute pancreatitis. 
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Crambene, the compound of our interest, has been shown to protect against acute 
pancreatitis by induction apoptosis in pancreas in vivo (Bhatia, Wallig et al. 1998). 
Moreover, crambene does not alter the interaction of CCK to its receptor on 
pancreatic acinar cells (Bhatia, Wallig et al. 1998). Therefore, crambene seems to be 
an ideal apoptotic inducer to study apoptosis of pancreatic acinar cells in caerulein-
induced experimental acute pancreatitis. However, the induction of apoptosis by 
crambene in pancreatic acinar cells has only been investigated in vivo. No study to-
date ever investigated its in vitro effect on isolated pancreatic acinar cells. 
 
Our current studies demonstrate for the first time, that crambene stimulates death 
signaling mechanisms in pancreatic acinar cells in vitro, including PS externalization, 
caspases activation, mitochondrial depolarization, and cytochrome c release leading 
to apoptosis. 
 
Besides defining the mechanisms of apoptosis in pancreatic acinar cell, our current 
studies lead a deeper understanding in the mechanisms by which induction of 
apoptosis in pancreatic acinar cells protects against acute pancreatitis. 
 
The role of phagocytotic clearance of apoptotic cells in regulation of immune 
responses has been shown in many experimental systems; however, no one ever 
related this important information with the protective effect of apoptosis in acute 
pancreatitis. To the best of our knowledge, we are the first to investigate the role of 
apoptosis and clearance of apoptotic cells, which regulates immune responses in acute 
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pancreatitis. Moreover, this is the first study to demonstrate that how the clearance of 
apoptotic cells regulates immune responses in acute pancreatitis. In addition, our 
primary culture system, which uses co-cultures of isolated pancreatic acinar cell with 
isolated resident peritoneal macrophages, is a total new in vitro approach to study the 
interaction between apoptotic acinar cells and phagocytes.  
 
In summary, this study helps define the mechanisms of apoptosis in pancreatic acinar 
cell and the mechanisms by which induction of apoptosis in pancreatic acinar cells is 
protective against acute pancreatitis. Specifically, this study, for the first time  
 
1. ascertained a pro-apoptotic effect of crambene in mouse pancreatic acinar 
cells in vitro as evidenced by externalization of PS and activation of caspase 3; 
 
2. demonstrated that the primary pathway involved in crambene-induced 
apoptosis of pancreatic acinar cell was mediated by loss of mitochondrial 
membrane potential, release of mitochondrial cytochrome c and activation of 
caspase 9; 
 
3. displayed that the protective effect of apoptosis against acute pancreatitis was 
mediated by down-regulation of pro-inflammatory mediators and up-
regulation of anti-inflammatory cytokines; 
 
4. recognized CD36 positive macrophages as a key player in phagocytic 
clearance of apoptotic acinar cells in acute pancreatitis; 
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5. established a role of anti-inflammatory pathways as the mechanism of 
apoptosis-mediated protection against acute pancreatitis. 
 
These findings would facilitate efforts to rationally manipulate the apoptotic 
machinery for therapeutic gain in the clinical management of patients with acute 
pancreatitis. The vast array of molecules observed involving in signaling pathways of 
apoptosis and anti-inflammatory pathways during clearance of apoptotic cells may 
offer diversified potential targets for therapeutic intervention. Deeper understanding 
into the mechanisms of apoptosis in pancreatic acinar cells and how it benefits against 
acute pancreatitis will facilitate the transition of the knowledge of apoptosis in 
pancreatic acinar cell from bench to bedside. 
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